Document:

EX-10.5

 Exhibit 10.5 

FORM OF 
 EMPLOYEE
MATTERS AGREEMENT 
 BY AND BETWEEN 

BAXTER INTERNATIONAL INC. 

AND 
 BAXALTA
INCORPORATED 
 DATED AS OF [—], 2015 

EMPLOYEE MATTERS AGREEMENT 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	 ARTICLE I DEFINITIONS
	  	 	1	  
	 Section 1.01
	 	 Defined Terms
	  	 	1	  
		
	 ARTICLE II GENERAL PRINCIPLES
	  	 	10	  
	 Section 2.01
	 	 Allocation of Liabilities
	  	 	10	  
	 Section 2.02
	 	 Employment with Baxalta
	  	 	12	  
	 Section 2.03
	 	 Establishment of Baxalta Plans
	  	 	13	  
	 Section 2.04
	 	 Non-Hire; Non-Solicit
	  	 	14	  
	 Section 2.05
	 	 Post-Distribution Employment in Deferred Baxalta Local Businesses
	  	 	15	  
	 Section 2.06
	 	 Collective Bargaining
	  	 	17	  
	 Section 2.07
	 	 Distributorship Model
	  	 	17	  
		
	 ARTICLE III U.S. AND PUERTO RICO QUALIFIED AND NON-QUALIFIED RETIREMENT PLANS
	  	 	17	  
	 Section 3.01
	 	 Baxalta Pension Plan
	  	 	17	  
	 Section 3.02
	 	 Incentive Investment Plan
	  	 	21	  
	 Section 3.03
	 	 Supplemental Pension Plan
	  	 	23	  
	 Section 3.04
	 	 Deferred Compensation Plan
	  	 	25	  
		
	 ARTICLE IV NON-U.S. RETIREMENT PLANS
	  	 	26	  
	 Section 4.01
	 	 Establishment of Non-U.S. Retirement Plans and Transfers of Assets and Liabilities
	  	 	26	  
	 Section 4.02
	 	 Shared Plan Model
	  	 	28	  
		
	 ARTICLE V WELFARE AND FRINGE BENEFIT PLANS
	  	 	31	  
	 Section 5.01
	 	 Health and Welfare Plans
	  	 	31	  
	 Section 5.02
	 	 COBRA and HIPAA
	  	 	34	  
	 Section 5.03
	 	 Vacation, Holidays and Leaves of Absence
	  	 	34	  
	 Section 5.04
	 	 Severance and Unemployment Compensation
	  	 	34	  
	 Section 5.05
	 	 Workers’ Compensation
	  	 	35	  
		
	 ARTICLE VI EQUITY, INCENTIVE, AND DIRECTOR AND EXECUTIVE COMPENSATION PROGRAMS
	  	 	35	  
	 Section 6.01
	 	 Equity Incentive Programs
	  	 	35	  
	 Section 6.02
	 	 Employee Stock Purchase Plan
	  	 	40	  
	 Section 6.03
	 	 Annual Bonus
	  	 	41	  
	 Section 6.04
	 	 Directors’ Plan
	  	 	41	  
	 Section 6.05
	 	 Directors’ Deferred Compensation Plan
	  	 	43	  
		
	 ARTICLE VII MISCELLANEOUS
	  	 	45	  
	 Section 7.01
	 	 Transfer of Records and Information
	  	 	45	  
	 Section 7.02
	 	 Cooperation
	  	 	45	  
	 Section 7.03
	 	 Employee Agreements
	  	 	45	  

  
 i 

							
	 Section 7.04
		 Repayment Assets
		 	45	  
	 Section 7.05
		 Compliance
		 	45	  
	 Section 7.06
		 Preservation of Rights
		 	46	  
	 Section 7.07
		 Reimbursement
		 	46	  
	 Section 7.08
		 Matching Grant Plan
		 	46	  
	 Section 7.09
		 Not a Change in Control
		 	46	  
	 Section 7.10
		 Incorporation by Reference
		 	46	  
	 Section 7.11
		 Limitation on Enforcement
		 	46	  
	 Section 7.12
		 Further Assurances and Consents
		 	47	  
	 Section 7.13
		 Third Party Consent
		 	47	  
	 Section 7.14
		 Effect if Distribution Does Not Occur
		 	47	  
	 Section 7.15
		 Disputes
		 	47	  
	 Section 7.16
		 Reverse Jurisdiction
		 	47	  

  
 ii 

 This EMPLOYEE MATTERS AGREEMENT dated as of
[—], 2015, is by and between BAXTER INTERNATIONAL INC., a Delaware corporation (“Baxter”), and BAXALTA INCORPORATED, a Delaware corporation (“Baxalta”). 

RECITALS: 
 WHEREAS, the
Baxter Board has determined that it is appropriate and advisable to separate the Baxalta Business from the Baxter Business; 
 WHEREAS, to
achieve the foregoing, the Parties have executed a Separation and Distribution Agreement which provides for, among other things, the contribution from Baxter to Baxalta of certain Assets, the assumption by Baxalta of certain Liabilities from Baxter,
the distribution by Baxter of Baxalta Common Stock to Baxter shareholders, and the execution and delivery of this Agreement and certain other agreements to facilitate and provide for the foregoing, in each case subject to the terms and conditions
set forth therein; 
 WHEREAS, the Employees of the Baxalta Business are currently employed by the Baxter Group and are expected to become
Employees of the Baxalta Group; and 
 WHEREAS, this Agreement describes the principal employment, compensation and employee benefit plan
arrangements between the Parties. 
 NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this
Agreement, the Parties hereby agree as follows: 
 AGREEMENT 

ARTICLE I 
 DEFINITIONS

 Section 1.01 Defined Terms. The following capitalized terms as used in this Agreement shall have the
meaning set forth below unless otherwise specified herein: 
 “Adjusted Baxter Award” means a Baxter Option or Baxter RSU
Award, as adjusted in accordance with Section 6.01(a). 
 “Adjusted Baxalta Stock Value” means the product
obtained by multiplying (i) the Baxalta When-Issued Price times (ii) the Distribution Ratio. 
 “Adjusted Option
Value” means (i) the Baxter Stock Value minus (ii) the per share exercise price of the Baxter Option immediately prior to the Distribution Date. 

“Affiliate” has the meaning set forth in the Separation and Distribution Agreement. 

“Agreement” means this Employee Matters Agreement and each of the Schedules hereto. 

“Applicable Closing Date” has the meaning set forth in Section 4.01(a). 

 “Asset” has the meaning set forth in the Separation and Distribution Agreement.

 “Baxalta” has the meaning set forth in the Preamble. 

“Baxalta Award” means a Baxalta Option, Baxalta PSU Award, or Baxalta RSU Award granted pursuant to Section 6.01.

 “Baxalta Benefit Plan” means, following the Distribution, each Benefit Plan sponsored by, maintained by, or contributed
to by the Baxalta Group, provided that such term shall include, following the consummation of a Local Closing Transaction, each Benefit Plan sponsored by, maintained by, or contributed to by the applicable Deferred Baxalta Local Business.

 “Baxalta Board” means the Baxalta board of directors. 

“Baxalta Business” has the meaning set forth in the Separation and Distribution Agreement. 

“Baxalta Change of Control” has the meaning set forth in Section 6.01(b). 

“Baxalta Common Stock” has the meaning set forth in the Separation and Distribution Agreement. 

“Baxalta DCP” means the Baxalta Incorporated and Subsidiaries Deferred Compensation Plan. 

“Baxalta Directors’ DCP” means the Baxalta Incorporated Directors’ Deferred Compensation Plan. 

“Baxalta Directors’ Plan” means the Baxalta Incorporated Non-Employee Director Compensation Plan. 

“Baxalta Employee” means any Employee who is (i) employed by the Baxalta Group as of immediately prior to the
Distribution Date, (ii) a Post-Distribution Baxalta Employee, (iii) designated prior to the Distribution Date by Baxter as an individual whose employment is to transfer from the Baxter Group to the Baxalta Group, whether or not such
transfer occurs prior to, upon or after the Distribution Date or (iv) designated as a Baxalta Employee by joint agreement of the Parties (in all cases, other than an Employee who is designated by Baxter prior to the Distribution Date as
intended not to transfer to the Baxalta Group). 
 “Baxalta Equity Plan” means the Baxalta Incorporated 2015 Equity Plan.

 “Baxalta ESPP” means the Baxalta Incorporated Employee Stock Purchase Plan. 

“Baxalta Former Employee” means a Former Employee who, immediately prior to such individual’s termination of employment
with or by the Baxter Group, either (i) was designated by Baxter as an Employee whose employment was to transfer to the Baxalta Group or (ii) if not 

  
 2 

 
so designated by Baxter, was primarily employed or engaged in the Baxalta Business (other than a Former Employee who was designated by Baxter as intended to become a Baxter Retained Employee).

 “Baxalta Group” means Baxalta and its Subsidiaries. 

“Baxalta Health and Welfare Plan” means, following the Distribution, a Health and Welfare Plan sponsored by, maintained by,
or contributed to by the Baxalta Group. 
 “Baxalta IIP” means the Baxalta Incorporated and Subsidiaries Incentive
Investment Plan. 
 “Baxalta Incentive Plan” means the Baxalta 2015 Incentive Plan. 

“Baxalta Pension Plan” means the Baxalta Incorporated and Subsidiaries Pension Plan. 

“Baxalta Percentage” means the quotient obtained by dividing (i) the Adjusted Baxalta Stock Value by (ii) the
Combined Stock Value. 
 “Baxalta Pre-Distribution Option Value” means the quotient obtained by dividing (i) the
product obtained by multiplying (A) the Adjusted Option Value times (B) the Baxalta Percentage by (ii) the Distribution Ratio. 

“Baxalta Retiree Health Care Plan” means the Baxalta Incorporated and Subsidiaries Retiree Plan. 

“Baxalta SERP” means the Baxalta Incorporated and Subsidiaries Supplemental Pension Plan. 

“Baxalta SIP” has the meaning set forth in Section 3.02(h). 

“Baxalta Stock Value” means the quotient obtained by dividing (i) the product obtained by multiplying (A) the
Baxter Stock Value by (B) the Baxalta Percentage, by (ii) the Distribution Ratio. 
 “Baxalta When-Issued Price”
means the volume weighted average per share price, as reported on the NYSE, of Baxalta Common Stock trading “when-issued” during Regular Trading Hours on the final five Trading Days immediately preceding the Effective Time. 

“Baxter” has the meaning set forth in the Preamble. 

“Baxter Benefit Plan” means a Benefit Plan sponsored by, maintained by, or contributed to by the Baxter Group. 

“Baxter Board” means the Baxter board of directors. 

“Baxter Business” has the meaning set forth in the Separation and Distribution Agreement. 

  
 3 

 “Baxter Change of Control” has the meaning set forth in
Section 6.01(b). 
 “Baxter Common Shares” has the meaning set forth in the Separation and Distribution
Agreement. 
 “Baxter Compensation Committee” means the compensation committee of the Baxter Board. 

“Baxter DCP” means the Baxter International Inc. and Subsidiaries Deferred Compensation Plan. 

“Baxter Directors’ DCP” means the Baxter International Inc. Directors’ Deferred Compensation Plan, as amended and
restated effective January 1, 2014. 
 “Baxter Directors’ Plan” means the Baxter International Inc. Non-Employee
Director Compensation Plan. 
 “Baxter ESPP” means the Baxter International Inc. Employee Stock Purchase Plan. 

“Baxter Ex-Distribution Price” means the volume weighted average per share price, as reported on the NYSE, of Baxter Common
Shares trading “ex-distribution” during Regular Trading Hours on the final five Trading Days immediately preceding the Effective Time. 

“Baxter Former Employee” means a Former Employee who is not a Baxalta Former Employee. 

“Baxter Group” means Baxter and its Subsidiaries (excluding, after the Distribution, any member of the Baxalta Group). 

“Baxter Health and Welfare Plan” means a Health and Welfare Plan sponsored by, maintained by, or contributed to by the Baxter
Group. 
 “Baxter IIP” means the Baxter International Inc. and Subsidiaries Incentive Investment Plan. 

“Baxter Pension Plan” means the Baxter International Inc. and Subsidiaries Pension Plan. 

“Baxter Percentage” means the quotient obtained by dividing (i) the Baxter Ex-Distribution Price by (ii) the
Combined Stock Value. 
 “Baxter Pre-Distribution Option Value” means the product obtained by multiplying (i) the
Adjusted Option Value times (ii) the Baxter Percentage. 
 “Baxter Pre-Distribution Stock Value” means the product
obtained by multiplying (i) the Baxter Stock Value by (ii) the Baxter Percentage. 
 “Baxter Puerto Rico Pension
Plan” shall have the meaning set forth in Section 3.01(h). 
 “Baxter Retained Employee” means any
Employee other than a Baxalta Employee. 

  
 4 

 “Baxter Retiree Health Care Plan” means the Baxter International Inc. and
Subsidiaries Retiree Plan. 
 “Baxter SERP” means the Baxter International Inc. and Subsidiaries Supplemental Pension Plan.

 “Baxter SIP” has the meaning set forth in Section 3.02(h). 

“Baxter Stock Programs” means, collectively, (i) the Baxter International Inc. 2000 Incentive Plan, (ii) the Baxter
International Inc. 2001 Incentive Plan, (iii) the Baxter International Inc. 2003 Incentive Plan, (iv) the Baxter International Inc. 2007 Incentive Plan, (v) the Baxter International Inc. 2011 Incentive Plan, (vi) the Baxter
International Inc. 2015 Incentive Plan, and (vii) any similar prior Baxter plans and all sub-plans or equity plans related to any of the foregoing, together with any incentive compensation program or arrangement that governs the terms of
equity-based incentive awards assumed by the Baxter Group in connection with a corporate transaction and that is maintained by the Baxter Group immediately prior to the Distribution Date, and any sub-plans established under those programs. 

“Baxter Stock Value” means the volume weighted average per share price, as reported on the NYSE, of Baxter Common Shares
trading “regular-way” during Regular Trading Hours on the final five Trading Days immediately preceding the Effective Time. 

“Benefit Plan” means any (i) “employee benefit plan,” as defined in ERISA Section 3(3) (whether or not
such plan is subject to ERISA); and (ii) employment, compensation, severance, salary continuation, bonus, thirteenth month, incentive, retirement, thrift, superannuation, savings, pension, workers’ compensation, termination benefit
(including termination notice requirements), termination indemnity, other indemnification, supplemental unemployment benefit, redundancy pay, profit sharing, deferred compensation, stock ownership, stock purchase, stock option, stock appreciation
right, restricted stock, “phantom” stock, performance share unit, restricted stock unit, other stock-based incentive, change in control, paid time off, perquisite, fringe benefit, vacation, disability, life, or other insurance, death
benefit, hospitalization, medical, or other compensatory or benefit plan, program, fund, agreement, arrangement, or policy of any kind (whether written or oral, qualified or nonqualified, funded or unfunded, foreign or domestic, currently effective
or terminated), and any trust, escrow or similar agreement related thereto, whether or not funded, excluding any plan, program, fund, agreement, arrangement, or policy (other than for workers’ compensation Liabilities) that is mandated by and
maintained solely pursuant to applicable Law. 
 “COBRA” means coverage required by Code Section 4980B or ERISA
Section 601 et. seq. 
 “Code” means the Internal Revenue Code of 1986, as amended. 

“Combined Stock Value” means the sum of (i) the Baxter Ex-Distribution Price and (ii) the Adjusted Baxalta Stock
Value. 
 “Conveyance and Assumption Instruments” has the meaning set forth in the Separation and Distribution Agreement.

  
 5 

 “Deferred Baxalta Local Business” has the meaning set forth in the Separation
and Distribution Agreement. 
 “Distribution” has the meaning set forth in the Separation and Distribution Agreement. 

“Distribution Date” has the meaning set forth in the Separation and Distribution Agreement. 

“Distribution Ratio” means the number of shares of Baxalta Common Stock distributed in the Distribution in respect of one
Baxter Common Share. 
 “Effective Time” has the meaning set forth in the Separation and Distribution Agreement. 

“Employee” means an employee of the Baxter Group or the Baxalta Group, as applicable, including any employee absent from work
on account of long-term disability or workers’ compensation leave (in each case, unless treated as a separated employee for employment purposes), vacation, jury duty, funeral leave, personal leave, sickness, short-term disability, military
leave, family leave, pay continuation leave, or other approved leave of absence or for whom an obligation to recall, rehire or otherwise return to employment exists under a contractual obligation or Law. 

“Employee Agreement” means any employment contract, whether written or unwritten, between a member of the Baxter Group and an
Employee or Former Employee, including any standard form employee agreement customarily signed by certain Employees of the Baxter Group and any other form of employment agreement signed or otherwise effective under applicable local Law. 

“Employee Recoupment Asset” means an employer’s right to repayment from an employee in respect of a tax equalization
payment, sign-on bonus payment, relocation expense payment, tuition payment, reimbursement, loan, or other similar item, including any agreement related thereto. 

“Employment Tax” means withholding, payroll, social security, workers’ compensation, unemployment, disability and any
similar tax imposed by any Tax Authority or social security authority, and any interest, penalties, additions to tax, or additional amounts with respect to the foregoing imposed on any taxpayer or consolidated, combined, or unitary group of
taxpayers. With respect to any Employment Tax, the term “Tax Authority” means the governmental entity or political subdivision thereof that imposes such Employment Tax, and the agency (if any) charged with the collection of such
Employment Tax for such entity or subdivision. 
 “ERISA” means the U.S. Employee Retirement Income Security Act of 1974,
as amended. 
 “ESOP” means an employee stock ownership plan, as defined in ERISA Section 407(d)(6) and Code
Section 4975(e)(7). 
 “Former Employee” means any individual whose employment with the Baxter Group terminated on or
prior to the Distribution Date, excluding any employee absent from work 

  
 6 

 
immediately prior to the Distribution Date on account of long-term disability or workers’ compensation leave (in each case, to the extent not treated as a separated employee for employment
purposes), vacation, jury duty, funeral leave, personal leave, sickness, short-term disability, military leave, family leave, pay continuation leave, or other approved leave of absence or for whom an obligation to recall, rehire or otherwise return
to employment exists under a contractual obligation or Law. 
 “Health and Welfare Plan” means any Benefit Plan established
or maintained to provide, through the purchase of insurance or otherwise, medical, dental, prescription, vision, short-term disability, long-term disability, death benefits, life insurance, accidental death and dismemberment insurance, business
travel accident insurance, employee assistance program, group legal services, wellness, cafeteria (including premium payment, health care flexible spending account, and dependent care flexible spending account components), travel reimbursement,
transportation, vacation benefits, apprenticeship or other training programs, day care centers, or prepaid legal services benefits, including any “employee welfare benefit plan” (as defined in ERISA Section 3(1)) that is not a
severance plan. 
 “HIPAA” means the Health Insurance Portability and Accountability Act of 1996, as amended. 

“Incurred Claim” means a Liability related to services or benefits provided under a Benefit Plan, and shall be deemed to be
incurred: (i) with respect to medical, dental, vision, and prescription drug benefits, upon the rendering of services giving rise to such Liability; (ii) with respect to death benefits, life insurance, accidental death and dismemberment
insurance, and business travel accident insurance, upon the occurrence of the event giving rise to such Liability; (iii) with respect to disability benefits, upon the date of disability, as determined by the disability benefit insurance carrier
or claim administrator, giving rise to such Liability; (iv) with respect to a period of continuous hospitalization, upon the date of admission to the hospital; and (v) with respect to tuition reimbursement or adoption assistance, upon
completion of the requirements for such reimbursement or assistance, whichever is applicable. 
 “International Commercial
Operations Agreement” has the meaning set forth in the Separation and Distribution Agreement. 
 “Law” has the
meaning set forth in the Separation and Distribution Agreement. 
 “Liabilities” has the meaning set forth in the
Separation and Distribution Agreement. 
 “Local Closing Transaction” means the local closing transaction involving a
Deferred Baxalta Local Business. 
 “Non-U.S. Baxter Benefit Plan” means a Baxter Benefit Plan established, maintained, or
contributed to by the Baxter Group that is primarily for the benefit of Employees or Former Employees who work primarily outside of the United States. 

“Non-U.S. Baxalta Benefit Plan” means a Baxalta Benefit Plan established, maintained, or contributed to by the Baxalta Group
that is primarily for the benefit of Employees or Former Employees who work primarily outside of the United States. 

  
 7 

 “Non-U.S. Baxalta Employee” means a Baxalta Employee who works primarily outside
of the United States. 
 “Non-U.S. Health and Welfare Plan” means a Health and Welfare Plan established, maintained, or
contributed to by the Baxter Group or the Baxalta Group, as applicable, that is primarily for the benefit of Employees (including Former Employees or Baxalta Former Employees, as appropriate) who work primarily outside of the United States. 

“Offering” has the meaning set forth in the Baxter ESPP. 

“Offering Commencement Date” has the meaning set forth in the Baxter ESPP. 

“Offering End Date” has the meaning set forth in the Baxter ESPP. 

“Option” means (i) when immediately preceded by “Baxter,” an option to purchase one or more Baxter Common
Shares granted under a Baxter Stock Program and outstanding immediately prior to the Distribution Date (whether or not then vested or exercisable); (ii) when immediately preceded by “Adjusted Baxter,” an option to purchase one or more
Baxter Common Shares adjusted in accordance with Section 6.01 or Section 6.04; and (iii) when immediately preceded by “Baxalta,” an option to purchase one or more shares of Baxalta Common Stock granted by
Baxalta in accordance with Section 6.01 or Section 6.04. 
 “Parties” means the parties to this
Agreement. 
 “Pension Eligibility Date” has the meaning set forth in Section 3.01(c)(i). 

“Pension Split Date” has the meaning set forth in Section 3.01(a). 

“Post-Distribution Baxalta Employee” means any Employee whose intended transfer from the Baxter Group to the Baxalta Group in
connection with the Distribution is to occur after the Distribution Date, including (i) each Employee named as a Post-Distribution Baxalta Employee in Schedule 1.01, which lists those Employees transferring only upon a Local Closing
Transaction if employed in connection with a Deferred Baxalta Local Business and (ii) any other Employee whose intended transfer from the Baxter Group to the Baxalta Group in connection with the Distribution is to occur after the Distribution
Date, including any Employee hired on or after the Distribution Date (but prior to the applicable Transfer Date) to the extent such Employee is primarily related to a Deferred Baxalta Local Business or is hired to replace any terminated or departing
Employee who would have otherwise been a Post-Distribution Baxalta Employee. 
 “PSU Award” means (i) when immediately
preceded by “Baxter,” a performance share unit award granted pursuant to a Baxter Stock Program and outstanding immediately prior to the Distribution Date; (ii) when immediately preceded by “Adjusted Baxter,” a performance
share unit award granted pursuant to a Baxter Stock Program adjusted in accordance with Section 6.01; and (iii) when immediately preceded by “Baxalta,” a performance share unit award granted by Baxalta in accordance with
Section 6.01. 

  
 8 

 “QDRO” means a qualified domestic relations order within the meaning of ERISA
Section 206(d) and Code Section 414(p). 
 “Regular Trading Hours” means the period beginning at 9:30 A.M. New
York City time and ending 4:00 P.M. New York City time. 
 “RSU Award” means (i) when immediately preceded by
“Baxter,” a restricted stock unit award granted pursuant to a Baxter Stock Program and outstanding immediately prior to the Distribution Date; (ii) when immediately preceded by “Adjusted Baxter,” a restricted stock unit
award granted pursuant to a Baxter Stock Program adjusted in accordance with Section 6.01 or Section 6.04; and (iii) when immediately preceded by “Baxalta,” a restricted stock unit award granted by Baxalta in
accordance with Section 6.01 or Section 6.04. 
 “Securities Act” means the U.S. Securities Act of
1933, as amended. 
 “Separation” has the meaning set forth in the Separation and Distribution Agreement. 

“Separation and Distribution Agreement” means the Separation and Distribution Agreement by and between the Parties, dated as
of [—], 2015. 
 “Shared Plan Replacement Date” means the date of the
establishment of the applicable Non-U.S. Baxalta Benefit Plan. 
 “Subsidiary” has the meaning set forth in the Separation
and Distribution Agreement. 
 “Trading Day” means the period of time during any given calendar day, commencing with the
determination of the opening price on the NYSE and ending with the determination of the closing price on the NYSE, in which trading and settlement in Baxter Common Shares or Baxalta Common Stock, as applicable, is permitted on the NYSE. 

“Transfer Date” means, with respect to each (i) Baxalta Employee (other than a Post-Distribution Baxalta Employee), the
Distribution Date; and (ii) Post-Distribution Baxalta Employee, the date on which such person first becomes employed by the Baxalta Group following the Distribution Date. With respect to each Post-Distribution Baxalta Employee who is not
employed by a Deferred Baxalta Local Business, “Transfer Date” means the date determined jointly by Baxter and Baxalta, or in the absence of such agreement, such date as Baxter may determine based on the facts and circumstances applicable
to such Post-Distribution Baxalta Employee. 
 “Transferred Employee” has the meaning set forth in
Section 2.02(a)(i). 
 “Transferred Flexible Spending Account Balances” has the meaning set forth in
Section 5.01(c)(iii). 
 “Transferred Non-U.S. Employee” means a Transferred Employee who works primarily
outside of the United States. 

  
 9 

 “Transition Services Agreement” has the meaning set forth in the Separation and
Distribution Agreement. 
 “United States” means, when used in a territorial sense, the fifty states of the United States
of America and the District of Columbia, but does not, unless otherwise specifically provided, include Puerto Rico or any other territory of the United States. 

“USERRA” means the Uniformed Services Employment and Reemployment Rights Act of 1994, as amended. 

ARTICLE II 
 GENERAL
PRINCIPLES 
 Section 2.01 Allocation of Liabilities. 

(a) Baxalta Liabilities. Except as expressly provided in this Agreement, Baxalta hereby assumes (or retains) and agrees to pay,
perform, fulfill, and discharge all Liabilities to the extent relating to, arising out of, or resulting from or with respect to: 

(i) the employment (or termination of employment), including with respect to any statutory or other Liabilities (whether those
Liabilities are otherwise the legal responsibility of the Baxter Group or the Baxalta Group) triggered by or in connection with the Separation, of each Transferred Employee by the Baxter Group up to the applicable Transfer Date and by the Baxalta
Group on and after the applicable Transfer Date (including, in each case, all Liabilities with respect to any such Baxalta Employee relating to, arising out of, or resulting from Employment Taxes, Employee Agreements, any Baxter Benefit Plan or any
Baxalta Benefit Plan); 
 (ii) the retention of any individual who is, or was, an independent contractor, temporary
employee, temporary service worker, consultant, freelancer, agency employee, leased employee, on-call worker, incidental worker, or non-payroll worker or any other individual in any other similar relationship to the extent the services provided by
any such individual were primarily related to the Baxalta Group or the Baxalta Business; provided that, for the avoidance of doubt, this Agreement is not intended to, and does not, address any Liabilities in respect of the services provided
by consulting firms, investment advisory firms, valuation advisory firms, legal advisors or other third-party entities retained to provide advice with respect to or in connection with the Separation and Distribution; and 

(iii) Liabilities and responsibilities expressly assumed or retained by Baxalta pursuant to this Agreement. 

(b) Baxter Liabilities. Except as expressly provided in this Agreement, the Separation and Distribution Agreement or any Ancillary
Agreement other than any Conveyance and Assignment Instrument (to the extent such Ancillary Agreement provides for allocation of Liability related to services to be provided after the Distribution Date), Baxter

  
 10 

 
hereby retains (or assumes) and agrees to pay, perform, fulfill, and discharge all Liabilities to the extent relating to, arising out of, or resulting from: 

(i) the employment (or termination of employment) of each Baxter Retained Employee by the Baxter Group prior to, on, or after
the Distribution Date (including all Liabilities with respect to any such Baxter Retained Employee to the extent relating to, arising out of, or resulting from Employment Taxes, Employee Agreements or any Baxter Benefit Plan); 

(ii) the employment (or termination of employment) of each Former Employee and each Baxalta Employee unless and until such
Baxalta Employee becomes a Transferred Employee (including all Liabilities to the extent relating to, arising out of, or resulting from Employment Taxes, Employee Agreements or any Baxter Benefit Plan); 

(iii) the retention of any individual who is, or was, an independent contractor, temporary employee, temporary service worker,
consultant, freelancer, agency employee, leased employee, on-call worker, incidental worker, non-payroll worker or any other individual in any other similar relationship to the extent the services provided by any such individual were primarily
related to the Baxter Group or the Baxter Business; provided that, for the avoidance of doubt, this Agreement is not intended to, and does not, address any Liabilities in respect of the services provided by consulting firms, investment
advisory firms, valuation advisory firms, legal advisors or other third-party entities retained to provide advice with respect to or in connection with the Separation and Distribution; and 

(iv) Liabilities and responsibilities expressly retained or assumed by Baxter pursuant to this Agreement. 

(c) Other Liabilities. To the extent that this Agreement does not cover particular Liabilities or responsibilities that relate to,
arise out of, or result from employment (or termination of employment), Employment Taxes, Employee Agreements or any Benefit Plan and the Parties later determine that they should be allocated in connection with the Separation, such Liabilities and
responsibilities shall be handled in a manner similar to the manner in which this Agreement handles comparable Liabilities and responsibilities, subject to the mutual agreement of the Parties. 

(d) Labor Relations. To the extent required by applicable Law or any contract or arrangement with a labor union, works council or
similar employee organization, Baxalta shall provide notice, engage in consultation and take any similar action which may be required after the Distribution Date on its part in connection with the Separation and shall fully indemnify each member of
the Baxter Group against any Liabilities arising from its failure to comply with such requirements. 

  
 11 

 Section 2.02 Employment with Baxalta. 

(a) Employment Transfers. The Parties intend for Baxalta Employees to transfer to the Baxalta Group and shall use their respective best
efforts and cooperate with each other to effectuate this intent. 
 (i) Except as otherwise mutually agreed upon by the
Parties, as of each Baxalta Employee’s Transfer Date, the Baxalta Group shall: (A) continue to employ (on a basis consistent with Section 2.02(b)) each Baxalta Employee employed in a jurisdiction where employment continues
automatically by operation of Law (and such individual does not object, where such right exists under applicable Law); (B) offer to employ (on a basis consistent with Section 2.02(b)) each Baxalta Employee employed in a jurisdiction
where employment does not continue automatically by operation of Law; and (C) offer to employ (on a basis consistent with Section 2.02(b) or as otherwise required by applicable Law) each Former Employee who would have been a Baxalta
Employee had such Former Employee been employed on the Distribution Date, and whose right to re-employment is protected by any applicable Law, including any Former Employee covered by USERRA. Each Baxalta Employee who accepts an offer of employment
with the Baxalta Group, or who continues employment with the Baxalta Group following his or her Transfer Date automatically by operation of Law (and does not object where such right exists under applicable Law), as the case may be, will be referred
to in this Agreement as a “Transferred Employee.” 
 (ii) The Baxter Group may terminate the employment of
any Baxalta Employee who does not become a Transferred Employee as of his or her intended Transfer Date, or, if such Baxalta Employee cannot be terminated in accordance with applicable Law or otherwise, then the Baxter Group may terminate any other
Employee of the Baxter Group whose employment (in the sole judgment of Baxter) is made redundant as a result of the continued retention of such Baxalta Employee. The Baxter Group may also terminate the employment of any Baxalta Employee if retaining
such Employee would constitute a violation of applicable Laws or the Baxter Code of Conduct. Baxalta will be responsible for, and will indemnify the Baxter Group from and against, any Liabilities incurred or payments made (including any severance
payments made) in connection with the termination of a Baxalta Employee or any other Employee of the Baxter Group pursuant to this Section 2.02(a)(ii) to the extent of any payment occurring on or after the Distribution Date. 

(b) Compensation and Benefits. 

(i) Except as expressly provided in this Agreement or in local Conveyance and Assumption Instruments, no Transferred Employee
shall participate in any Baxter Benefit Plan following his or her Transfer Date. 
 (ii) Except as expressly provided in
this Agreement or as otherwise required by applicable Law, the Baxalta Group shall provide to each Transferred Employee as of his or her Transfer Date (A) base salary at the same rate as provided to that Transferred Employee immediately prior
to the Transfer Date, (B) cash 

  
 12 

 
incentive compensation opportunities that are comparable in the aggregate to those offered under the corresponding Baxter Benefit Plan(s) immediately prior to the Transfer Date, and
(C) benefits under the other Baxalta Benefit Plans that are comparable in the aggregate to benefits provided under the corresponding Baxter Benefit Plans immediately prior to the Transfer Date. Nothing in the preceding sentence shall prevent
the Baxalta Group from modifying the compensation and benefits of a Transferred Employee after such Transferred Employee’s Transfer Date. 

(c) Service Credit. Except as otherwise expressly provided in this Agreement or to the extent it would result in a duplication of
benefits, Baxalta and each Baxalta Benefit Plan shall, to the extent permitted in accordance with applicable Law, give each Transferred Employee credit for all service with the Baxter Group and shall calculate such service as it would be calculated
by Baxter or under the corresponding Baxter Benefit Plan as of the applicable Transfer Date. 
 Section 2.03 Establishment
of Baxalta Plans. 
 (a) Generally. 

(i) U.S. Prior to the Distribution Date, Baxalta shall adopt Benefit Plans (and related trusts, if applicable, as
determined by the Parties) with terms comparable in the aggregate to those of the corresponding Baxter Benefit Plans in the U.S., including in particular those listed in Schedule 2.03(a); provided, however, that Baxalta may
limit participation in any Baxalta Benefit Plan to Transferred Employees who participated in the corresponding Baxter Benefit Plan immediately prior to the applicable Transfer Date. 

(ii) Non-U.S. (excluding Puerto Rico). Prior to the Distribution Date, the Baxalta Group shall, except as otherwise
mutually agreed upon by the Parties, adopt Non-U.S. Baxalta Benefit Plans (excluding Non-U.S. Baxalta Benefit Plans with respect to Non-U.S. Baxalta Employees residing in Puerto Rico), with terms comparable in the aggregate to those of the
corresponding Non-U.S. Baxter Benefit Plans; provided, however, that Baxalta may limit participation in any such Non-U.S. Baxalta Benefit Plan to Non-U.S. Baxalta Employees who are Transferred Employees and who participated in the
corresponding Non-U.S. Baxter Benefit Plan immediately prior to the applicable Transfer Date. As described in Article IV, or as otherwise mutually agreed upon by the Parties from time to time, the Baxter Group shall, or shall cause the
applicable Non-U.S. Baxter Benefit Plan’s related trust to, transfer to the Baxalta Group or the relevant Non-U.S. Baxalta Benefit Plan’s related trust, an amount equal to the trust Assets, insurance reserves, and other Assets of each
Non-U.S. Baxter Benefit Plan relating to the Liabilities of such Non-U.S. Baxter Benefit Plan assumed by Baxalta or such Non-U.S. Baxalta Benefit Plan in accordance with this paragraph. To the extent a Non-U.S. Baxter Benefit Plan is not required to
be funded by applicable Law or is not voluntarily funded, there shall be no transfer of assets by the Non-U.S. Baxter Benefit Plan or by the Baxter Group. As described in Article IV, or as otherwise mutually agreed upon by the Parties
from time to time, the Baxalta Group shall, or shall cause the relevant Non-U.S. Baxalta Benefit Plan to, assume the Liabilities of the corresponding Non-U.S. 

  
 13 

 
Baxter Benefit Plan with respect to all benefits accrued under that Non-U.S. Baxter Benefit Plan by Non-U.S. Baxalta Employees (other than Non-U.S. Employees residing in Puerto Rico) who are
Transferred Employees. 
 (iii) Puerto Rico. Prior to the Distribution Date, the Baxalta Group shall, except as
otherwise provided in Article III or as mutually agreed upon by the Parties, adopt Non-U.S. Baxalta Benefit Plans with respect to Non-U.S. Baxalta Employees residing in Puerto Rico, with terms comparable in the aggregate to those of the
corresponding Non-U.S. Baxter Benefit Plans; provided, however, that Baxalta may limit participation in any such Non-U.S. Baxalta Benefit Plan to Non-U.S. Baxalta Employees who are Transferred Employees and who participated in the
corresponding Non-U.S. Baxter Benefit Plan immediately prior to the applicable Transfer Date; provided further that to the extent permitted by applicable Law, the Baxalta Group may provide for Non-U.S. Baxalta Employees residing in
Puerto Rico to participate in a Baxalta Benefit Plan maintained for Baxalta Employees residing in the United States, in which event such Baxalta Benefit Plan shall be considered a Non-U.S. Baxalta Benefit Plan with respect to the portion applicable
to such Non-U.S. Baxalta Employees. As described in Article III, or as otherwise mutually agreed upon by the Parties from time to time, the Baxter Group shall, or shall cause the applicable Non-U.S. Baxter Benefit Plan’s related trust
to, transfer to the Baxalta Group or the relevant Non-U.S. Baxalta Benefit Plan’s related trust, an amount equal to the trust Assets, insurance reserves, and other Assets of each Non-U.S. Baxter Benefit Plan relating to the Liabilities of such
Non-U.S. Baxter Benefit Plan assumed by Baxalta or such Non-U.S. Baxalta Benefit Plan in accordance with this paragraph. As described in Article III, or as otherwise mutually agreed upon by the Parties from time to time, the Baxalta Group
shall, or shall cause the relevant Non-U.S. Baxalta Benefit Plan to, assume the Liabilities of the corresponding Non-U.S. Baxter Benefit Plan with respect to all benefits accrued under that Non-U.S. Baxter Benefit Plan by Non-U.S. Baxalta Employees
residing in Puerto Rico who are Transferred Employees. 
 (b) Plan Information and Operation. Baxter shall provide Baxalta with
information describing each Baxter Benefit Plan election made by a Transferred Employee that may have application following the applicable Transfer Date. Baxalta shall determine, in its sole discretion, whether to administer the Baxalta Benefit
Plans using those elections or to require Transferred Employees to submit new elections with respect to the Baxalta Benefit Plans. Except as provided in this Agreement, the Distribution and the transfer of any Employee’s employment to the
Baxalta Group shall not cause a distribution from or payment of benefits under any Baxter Benefit Plan. Each Party shall, upon reasonable request, provide the other Party and the other Party’s respective Affiliates, agents, and vendors all
information reasonably necessary to the other Party’s operation or administration of its Benefit Plans. 
 Section 2.04
Non-Hire; Non-Solicit. 
 (a) As of the Distribution Date and until the second anniversary of the Distribution
Date, Baxter shall not, and shall cause the Baxter Group not to, solicit or hire or continue to keep employed (whether as an employee, consultant, contractor or otherwise) (i) any Baxalta Employee who was an Employee of the Baxter Group or
Baxalta Group at any time 

  
 14 

 
during the six months prior to the Distribution Date; or (ii) any Baxalta Employee who has rejected any offer of employment made by the Baxalta Group in connection with
Section 2.02(a)(i) (subject in each case to the terms of Section 2.02(a)(ii)); provided, however, that nothing in this Section 2.04(a) shall prohibit the Baxter Group from soliciting or hiring any
individual who is involuntarily terminated by the Baxalta Group, or from continuing to employ any Post-Distribution Baxalta Employee. 

(b) As of the Distribution Date and until the second anniversary of the Distribution Date, Baxalta shall not, and shall cause the Baxalta
Group not to, solicit or hire (whether as an employee, consultant, contractor or otherwise) (i) any Baxter Retained Employee or Baxter Former Employee who was an Employee of the Baxter Group or the Baxalta Group within six months prior to the
Distribution Date; or (ii) any Baxter Employee employed by the Baxalta Group who rejected any offer of employment made by the Baxter Group in connection with the Separation and Distribution; provided, however, that nothing in this
Section 2.04(b) shall prohibit the Baxalta Group from soliciting or hiring any individual who is involuntarily terminated by the Baxter Group, from continuing to employ any Baxter Employee as required by applicable Law, or from employing
any Baxter Employee (if any) whose transfer date to the Baxter Group by agreement of the Parties will occur after the Distribution Date. 

(c) The Parties specifically acknowledge and agree that this provision is necessary to ensure stabilization of both companies after the
Distribution and does not impede either company from competing in the marketplace or obtaining sufficient talent to effectively innovate, develop, grow, or sustain their respective businesses. 

(d) The Parties further specifically acknowledge and agree that any remedy at law for any breach of this Section 2.04 shall be
inadequate and that in the event of any actual or threatened breach of this Section 2.04, the non-breaching party, in addition to any other relief available to it, shall be entitled to temporary and permanent injunctive relief without
the necessity of proving actual damage. 
 (e) The Parties specifically acknowledge and agree that an exception may be made to this
provision at the sole discretion and with the written consent of the CVPs, Human Resources of each Party. Any exception made shall not be used as precedent to compel or allow any further exceptions. 

Section 2.05 Post-Distribution Employment in Deferred Baxalta Local Businesses. The following provisions
shall apply to the Deferred Baxalta Local Businesses: 
 (a) During the period commencing on the Distribution Date and ending on the
applicable Transfer Date, Baxter or its appropriate Affiliate shall manage the employment of each Post-Distribution Baxalta Employee consistently with its management of the employment of similar Baxter Employees in the ordinary course of business
(including with respect to compensation, annual and other bonuses, and other compensation, subject to Section 2.05(a)(iii)(E) below); provided that Baxter and its Affiliates shall have no obligation to make any equity grant or
provide any other equity incentive to any Post-Distribution Baxalta Employee on or after the Distribution Date, and Baxalta shall have no obligation to Baxter or any of its Affiliates in respect of any equity grant or other equity incentive that is
provided by Baxter 

  
 15 

 
or its appropriate Affiliate to any Post-Distribution Baxalta Employee on or after the Distribution Date unless and except Baxter and Baxalta have agreed in writing otherwise. Baxalta shall be
responsible for all cash compensation liabilities arising during such period; provided that the payment and reimbursement for such amounts shall occur in accordance with the International Commercial Operations Agreement. Baxter shall until
the time of the applicable Local Closing Transaction (or such other Transfer Date with respect to any Post-Distribution Baxalta Employee): 

(i) provide Baxalta or its appropriate Affiliate with notice of (A) any material amendment to the Baxter Code of Conduct
to the extent applicable to the employment of a Post-Distribution Baxalta Employee or (B) the termination of any Post-Distribution Baxalta Employee due to a violation or potential violation of Law or the Baxter Code of Conduct, or otherwise
pursuant to Section 2.02(a)(ii); 
 (ii) provide Baxalta or its appropriate Affiliate with at least 30
days’ advance written notice prior to (A) making any material substantive change to the Employee Agreement of a Post-Distribution Baxalta Employee unless such change is required by applicable Law; (B) making any change to the base
salary of a Post-Distribution Baxalta Employee, other than an increase in the ordinary course of business (including any change required by Law or any contract existing as of the Distribution Date or otherwise approved by Baxalta) based on the
Employee’s performance rating or seniority; or (C) making any modification to a Baxter Benefit Plan in which a Post-Distribution Baxalta Employee participates if such modification would result in a significant change in the cost of such
plan to the employer or the participant; and 
 (iii) consult with and request a recommendation from Baxalta or its
appropriate Affiliate prior to (A) hiring any individual (other than in the ordinary course to replace any individual whose employment has terminated, in which case Baxter shall consult with Baxalta or its appropriate Affiliate prior to such
hiring) who will be classified as a Baxalta Employee unless such headcount addition was authorized prior to the Distribution Date, (B) terminating any Post-Distribution Baxalta Employee, except due to a violation of Law or the Baxter Code of
Conduct, or otherwise pursuant to Section 2.02(a)(ii), (C) promoting any Post-Distribution Baxalta Employee to a position of Vice President or higher unless such promotion was authorized prior to the Distribution Date,
(D) demoting any Post-Distribution Baxalta Employee, transferring any Post-Distribution Baxalta Employee to a location more than 20 miles from such Baxalta Employee’s current office location, or otherwise materially changing the role or
responsibility of any Post-Distribution Baxalta Employee or (E) establishing targets or goals for bonus and other incentive compensation awards granted to Post-Distribution Baxalta Employees by Baxter or any member of the Baxter Group. 

(b) Except as otherwise mutually agreed upon by the Parties (such as in a Conveyance and Assumption Instrument or other agreement), if a
Baxalta Employee’s transfer of employment to the Baxalta Group upon the consummation of a Local Closing Transaction or otherwise causes, at the time of such transfer, a forfeiture of awards granted prior to the Distribution Date under a Baxter
Stock Program (or successor thereto), Baxter shall not have any obligation, Liability or responsibility to such Baxalta Employee with respect to such 

  
 16 

 
forfeited awards, and Baxalta shall equitably compensate the affected Baxalta Employee for such forfeited awards in a manner determined by Baxalta in its sole discretion. The foregoing sentence
shall not preclude the Parties from making arrangements, if allowed by the Baxter Stock Program (or successor thereto) and applicable Law, to permit affected Baxalta Employees to continue to hold, after the Local Closing Transaction or other
Transfer Date, awards granted prior to the Distribution Date under a Baxter Stock Program (or successor thereto). 
 Section 2.06
Collective Bargaining. Baxalta shall cause the appropriate member of the Baxalta Group to assume all Liabilities arising under any collective bargaining agreement (including but not limited to any national, sector or local collective
bargaining agreement) with respect to any Transferred Employee. To the extent necessary, Baxalta shall cause the appropriate member of the Baxalta Group to join any industrial, employer or similar association or federation if membership is required
for the relevant collective bargaining agreement to continue to apply. 
 Section 2.07 Distributorship Model. In the
event that Baxalta operates any Deferred Baxalta Local Business through a local distributor rather than through an Affiliate, Baxalta agrees to use its best efforts to cause such local distributor to employ the Baxalta Employees on similar terms and
conditions of employment. 
 ARTICLE III 

U.S. AND PUERTO RICO QUALIFIED AND NON-QUALIFIED RETIREMENT PLANS 

Section 3.01 Baxalta Pension Plan. 

(a) Establishment of Baxalta Pension Plan. Effective on or about May 1, 2015, Baxalta shall establish the Baxalta Pension Plan
(such effective date, the “Pension Split Date”), which shall be substantially similar to, and which shall include benefit formulas that are the same as the benefit formulas in effect under, the Baxter Pension Plan as of the Pension
Split Date. As soon as practicable after the Pension Split Date and upon receipt by Baxter of (i) a copy of the Baxalta Pension Plan; (ii) copies of certified resolutions of the Baxalta Board (or its authorized committee or other delegate)
evidencing adoption of the Baxalta Pension Plan and any related trust(s) and the assumption by the Baxalta Pension Plan of the Liabilities described in Section 3.01(b); and (iii) either (A) a favorable determination letter
issued by the Internal Revenue Service with respect to the Baxalta Pension Plan and any related trust, or (B) an opinion of counsel, which counsel and opinion are reasonably satisfactory to Baxter, with respect to the qualified status of
the Baxalta Pension Plan under Code Section 401(a) and the tax-exempt status of any related trust under Code Section 501(a) (which opinion of counsel may assume that Baxalta will make a timely application for a determination letter and
adopt any amendments required by the Internal Revenue Service as a condition to receipt of such letter), Baxter shall direct the trustee of the trust described in the Baxter International Inc. and Subsidiaries Pension Trust Agreement to make the
transfer of Assets described in Section 3.01(b). 

  
 17 

 (b) ERISA Section 4044 Transfer. 

(i) As of the Pension Split Date, Baxalta shall cause the Baxalta Pension Plan to accept all Assets and assume all Liabilities
under the Baxter Pension Plan for Transferred Employees (other than Post-Distribution Baxalta Employees) (including Assets and Liabilities in respect of beneficiaries and alternate payees) and the Baxter Pension Plan shall transfer all such Assets
and be relieved of such Liabilities; provided that, if any such Assets or Liabilities are transferred to the Baxalta Pension Plan on or prior to the Distribution Date in respect of any participant who does not become a Transferred Employee as
of the Distribution Date, Baxter and Baxalta shall cause such Assets and Liabilities to be promptly returned to (and assumed by) the Baxter Pension Plan (effective as of the Distribution Date), with Assets and Liabilities in respect of employees who
are not Transferred Employees as of the Distribution Date to be transferred to the Baxalta Pension Plan only to the extent set forth in Section 3.01(b)(ii). The amount of Assets to be transferred from the Baxter Pension Plan to the
Baxalta Pension Plan in such transfer (or transfers) shall be determined as of the Pension Split Date in accordance with, and shall comply with, Code Section 414(l) and, to the extent deemed applicable by the Parties, ERISA Section 4044.
Assumptions used to determine the value (or amount) of the Assets to be transferred shall be the safe harbor assumptions specified for valuing benefits in trusteed plans under Department of Labor Regulations Section 4044.51-57 and, to the
extent not so specified, shall be based on the assumptions used in the annual valuation report most recently prepared prior to the transfer by the actuary for the Baxter Pension Plan. The transfer amount described above shall be credited or debited,
to the extent applicable, with a pro rata share of the actual investment earnings or losses allocable to the transfer amount for the period between the Pension Split Date (or such earlier transfer date) and an assessment date set by Baxter that is
as close as practicable, taking into account the timing and reporting of valuation of assets in the trust or trusts described in the Baxter International Inc. and Subsidiaries Pension Trust Agreement, to the date upon which Assets equal in value to
the transfer amount are actually transferred from the Baxter Pension Plan to the Baxalta Pension Plan. The ultimate transfer amount shall be credited or debited by the actual investment earnings or losses from the payment date to the assessment date
set by Baxter above. In addition, during this period, Baxalta will be responsible for a pro rata share of trustee and administration fees attributable to the Baxalta Pension Plan assets that remain in the Baxter Pension Plan. The funding balances
and shortfall amortization installments shall be divided among the Baxter Pension Plan and the Baxalta Pension Plan based on the guidance provided in Revenue Ruling 81-212 and 86-47. 

(ii) As indicated in Section 3.01(b)(i), the Parties anticipate that the Baxalta Pension Plan accept Assets and
assume all Liabilities under the Baxter Pension Plan for Transferred Employees on or prior to the Distribution Date. Notwithstanding such transfer and assumption on or prior to the Distribution Date, the Parties acknowledge and agree that
adjustments (including of the type described in Section 3.01(b)(i)) may be necessary after the Distribution Date to finalize the intent of Section 3.01(b)(i). Any such adjustments (including the transfer and assumption of
Assets and Liabilities in respect thereof) will, unless the Parties have determined that the amount is significant enough to require earlier discussion, be made on or about December 31, 2015. The amount of such Assets to be transferred shall be
determined as provided in Section 3.01(b)(i) and shall be subject to the applicable provisions of Section 3.01(b)(i). 

  
 18 

 (iii) If a participant in the Baxter Pension Plan who is scheduled to become a
Transferred Employee terminates employment after the Pension Split Date, but before such participant’s Transfer Date, such participant’s benefit will be paid entirely by the Baxter Pension Plan (and shall include any compensation paid and
service earned after the Pension Split Date) and, to the extent such benefit was taken into account in determining the amount of Assets transferred to the Baxalta Pension Plan, an appropriate adjustment shall be made. If a Transferred Employee
terminates from the Baxalta Group after such Transferred Employee’s Transfer Date, but before the transfer of Assets is completed, such Transferred Employee’s benefit may initially be paid by the Baxter Pension Plan, but shall be paid by
the Baxalta Pension Plan after the Asset transfer is completed, with any payment made by the Baxter Pension Plan in accordance with this sentence credited against the amount transferred to the Baxalta Pension Plan. 

(iv) Periodically, at such times as agreed upon by the Parties after the initial transfer described in
Section 3.01(b)(i), Baxalta shall cause the Baxalta Pension Plan to receive Assets and assume all Liabilities under the Baxter Pension Plan with respect to Post-Distribution Baxalta Employees who become Transferred Employees (including
Assets and Liabilities in respect of beneficiaries and/or alternate payees) and the Baxter Pension Plan shall transfer all such Assets and be relieved of such Liabilities. The amount of such Assets to be transferred shall be determined as provided
in Section 3.01(b)(i). 
 (c) Baxalta Pension Plan Provisions. The Baxalta Pension Plan shall provide that: 

(i) Transferred Employees shall (A) be eligible to participate in the Baxalta Pension Plan as of the Pension Split Date,
or as of the applicable Transfer Date with respect to Post-Distribution Baxalta Employees (in either case, the “Pension Eligibility Date”) to the extent they were eligible to participate in the Baxter Pension Plan as of the Pension
Eligibility Date, and (B) receive credit for vesting, eligibility and benefit service for all service credited for those purposes under the Baxter Pension Plan as of the Pension Eligibility Date as if that service had been rendered to Baxalta;

 (ii) the compensation paid by the Baxter Group to a Transferred Employee that is recognized under the Baxter Pension
Plan as of the Pension Eligibility Date shall be credited and recognized for all applicable purposes under the Baxalta Pension Plan as though it were compensation from the Baxalta Group; 

(iii) the accrued benefit of each Transferred Employee under the Baxter Pension Plan as of the applicable Pension Eligibility
Date shall be payable under the Baxalta Pension Plan at the time and in a form that would have been permitted under the Baxter Pension Plan as in effect as of the applicable Pension Eligibility Date, with employment by the Baxter Group prior to the
applicable Pension Eligibility Date treated as employment by the Baxalta Group under the Baxalta Pension Plan for purposes of determining eligibility for optional forms of benefit, early retirement benefits, or other benefit forms; provided
that nothing herein shall preclude Baxalta from changing the forms of benefit available under the Baxalta Pension Plan to the extent permitted by Code Section 411(d)(6); 

  
 19 

 (iv) the Baxalta Pension Plan shall assume and honor the terms of all QDROs in
effect under the Baxter Pension Plan as of the Pension Eligibility Date with respect to Transferred Employees; and 
 (v)
the Baxalta Pension Plan shall provide the additional benefit accruals, if any, required by USERRA for a Former Employee who is employed by the Baxalta Group following the Distribution Date pursuant to Section 2.02(a)(i)(C), including
any amount that relates to the period of military leave that occurred prior to the Distribution Date. 
 (d) Determination Letter
Request. Baxalta shall submit an application to the Internal Revenue Service and the Puerto Rico Department of the Treasury either prior to, or as soon as practicable after, the Pension Split Date (but no later than the last day of the remedial
amendment period as defined in applicable Code provisions) for a determination letter regarding the qualification of the Baxalta Pension Plan and the tax status of its related trust as of the Pension Split Date and shall make any amendments
reasonably requested by the Internal Revenue Service to receive a favorable determination letter regarding the Baxalta Pension Plan. 
 (e)
Baxter Pension Plan after Distribution Date. From and after the Pension Split Date, (i) the Baxter Pension Plan shall continue to be responsible for Liabilities in respect of Employees other than Transferred Employees (and for
Post-Distribution Baxalta Employees until their respective Transfer Dates), and (ii) no Employees of the Baxalta Group (other than Post-Distribution Baxalta Employees until their respective Transfer Dates) shall accrue any benefits under the
Baxter Pension Plan. Without limiting the generality of the foregoing, Transferred Employees shall cease to be active participants in the Baxter Pension Plan effective as of the applicable Pension Eligibility Date. 

(f) Plan Fiduciaries. Prior to the Distribution Date, Baxter’s Administrative Committee and the Investment Committee shall act as
the fiduciaries for the Baxalta Pension Plan as necessary. For all periods after the Distribution Date, the Parties agree that the applicable fiduciaries of each of the Baxter Pension Plan and the Baxalta Pension Plan, respectively, shall have the
authority with respect to the Baxter Pension Plan and the Baxalta Pension Plan, respectively, to determine the plan investments and such other matters as are within the scope of their duties under ERISA Section 404. 

(g) No Loss of Unvested Benefits; No Distributions. The transfer of any Transferred Employee’s employment to the Baxalta Group
will not result in loss of that Transferred Employee’s unvested benefits under the Baxter Pension Plan or the Baxalta Pension Plan and no Transferred Employee shall be entitled to a distribution of his or her benefit under the Baxter Pension
Plan as a result of such transfer of employment. 
 (h) Puerto Rico Employees. Transferred Employees who are participants in the
Baxter Healthcare of Puerto Rico Pension Plan (the “Baxter Puerto Rico Pension Plan”) will have their benefits transferred to the Baxalta Pension Plan as of the Pension 

  
 20 

 
Split Date such that Assets transferred to the Baxalta Pension Plan will equal the present value of accrued benefits using reasonable actuarial assumptions. The terms of the Baxalta Pension Plan
will include terms providing that the benefits of such Transferred Employees will be determined in accordance with the terms of the Baxter Puerto Rico Pension Plan to the extent such terms differ from those of the Baxter Pension Plan, except as
otherwise required by applicable Law. 
 Section 3.02 Incentive Investment Plan. 

(a) Establishment of Baxalta Incentive Investment Plan. Effective as of or before the Distribution Date, Baxalta shall establish the
Baxalta IIP. As of the Distribution Date, the terms of the Baxalta IIP shall be substantially similar to the terms of the Baxter IIP as of the Distribution Date; provided that the investment options may be different under the Baxalta IIP. On
or prior to the Distribution Date, Baxalta shall provide Baxter with (i) a copy of the Baxalta IIP; (ii) a copy of certified resolutions of the Baxalta Board (or its authorized committee or other delegate) evidencing adoption of the
Baxalta IIP and the related trust(s) and the assumption by the Baxalta IIP of the Liabilities described in Section 3.02(b); and (iii) either (A) a favorable determination letter issued by the Internal Revenue Service with
respect to the Baxalta IIP and its related trust or (B) an opinion of counsel, which counsel and opinion are reasonably satisfactory to Baxter, with respect to the qualified status of the Baxalta IIP under Code Section 401(a) and the
tax-exempt status of its related trust under Code Section 501(a) (which opinion of counsel may assume that Baxalta will make a timely application for a determination letter and adopt any amendments required by the Internal Revenue Service as a
condition to receipt of such letter). 
 (b) Transfer of Account Balances. As soon as practicable after the Distribution Date,
Baxter shall cause the trustee of the Baxter IIP to transfer from the trust(s) which forms a part of the Baxter IIP to the trust(s) which forms a part of the Baxalta IIP amounts equal to the account balances of the Transferred Employees (including
account balances in respect of beneficiaries and alternate payees established in relation to such individuals) under the Baxter IIP, determined as of the date of the transfer. Such transfers shall be made in cash, Baxter Common Shares, shares of
Baxalta Common Stock, promissory notes evidencing outstanding loans and other Assets (including common shares of Edwards Lifesciences or Cardinal Health, Inc.) or any combination thereof in cash or in kind, as instructed by the Baxter IIP or the
investment committee thereof. Baxalta shall cause the transferred amounts to be allocated among the Transferred Employees’ (and beneficiaries’ and/or alternate payees’, as applicable) Baxalta IIP accounts and to be allocated to the
same investment funds as the accounts were allocated under the Baxter IIP to the extent that such investment funds are available under the Baxalta IIP and, to the extent such investment funds are not available, in the manner determined by the
fiduciaries of the Baxalta IIP. Any Asset and Liability transfers pursuant to this Section 3.02 shall comply in all respects with Code Sections 414(l) and 411(d)(6). 

(c) Baxalta Incentive Investment Plan Provisions. The Baxalta IIP shall provide that: 

(i) Transferred Employees shall (A) be eligible to participate in the Baxalta IIP as of the applicable Transfer Date to
the extent they were eligible to participate in the Baxter IIP as of the applicable Transfer Date, and (B) receive credit for vesting purposes for all service credited for that purpose under the Baxter IIP as of the applicable Transfer Date as
if that service had been rendered to Baxalta; 

  
 21 

 (ii) the account balance of each Transferred Employee under the Baxter IIP as of
the date of the transfer of Assets from the Baxter IIP (including any outstanding promissory notes) shall be credited to such individual’s account balance under the Baxalta IIP; 

(iii) the Baxalta IIP shall assume and honor the terms of all QDROs in effect under the Baxter IIP as of the Transfer Date
with respect to Transferred Employees; 
 (iv) Baxalta shall contribute to the Baxalta IIP on behalf of each Transferred
Employee an amount equal to any Matching Contributions, as defined in the Baxter IIP, that relate to Elective Deferrals made by such Transferred Employee prior to the Transfer Date, and who is not entitled to have 2015, or any portion thereof,
treated as a year of service for purposes of determining such Transferred Employee’s accrued benefit as defined in either the Baxter Pension Plan, the Baxter Puerto Rico Pension Plan, or the Baxalta Pension Plan, but that were not made to the
Baxter IIP prior to the Transfer Date due to limitations under the Baxter IIP on the maximum amount of Matching Contributions made in any payroll period; 

(v) Baxalta shall contribute to the Baxalta IIP on behalf of each Transferred Employee who is employed on the last day of 2015
(or whose employment is terminated from the Baxalta Group by reason of death or disability following the applicable Transfer Date) an Employer Non-Matching Contribution (as such term is used in the Baxter IIP) calculated as provided in
Section 5.8 of the Baxter IIP, based upon the Transferred Employee’s total compensation for the Baxter Group and the Baxalta Group during 2015; and 

(vi) the Baxalta IIP shall provide the opportunity to make up Elective Deferrals, and any employer contributions, required by
USERRA for a Former Employee who is employed by the Baxalta Group following the Distribution Date pursuant to Section 2.02(a)(i)(C), including any amount that relates to the period of military leave that occurred prior to the
Distribution Date. 
 (d) Determination Letter Request. Baxalta shall submit an application to the Internal Revenue Service either
prior to, or as soon as practicable following, the Distribution Date (but no later than the last day of the remedial amendment period as defined in applicable Code provisions) for a determination regarding the qualification of the Baxalta IIP and
the tax-exempt status of its related trust as of the Distribution Date and shall make any amendments reasonably requested by the Internal Revenue Service to receive a favorable determination letter regarding the Baxalta IIP. 

(e) Baxter Incentive Investment Plan after Distribution Date. From and after the Distribution Date, (i) the Baxter IIP shall
continue to be responsible for Liabilities in respect of Baxter Retained Employees, Former Employees and (until the applicable Transfer 

  
 22 

 
Date) Post-Distribution Baxalta Employees, and (ii) no Employees of the Baxalta Group (other than Post-Distribution Baxalta Employees until their respective Transfer Dates), shall accrue any
benefits under the Baxter IIP. Without limiting the generality of the foregoing, Transferred Employees shall cease to be active participants in the Baxter IIP effective as of the applicable Transfer Date. 

(f) Plan Fiduciaries and Stock Considerations. Prior to the Distribution Date, Baxter’s Administrative Committee and Investment
Committee shall act as the fiduciaries for the Baxalta IIP as necessary. Without limiting the generality of the foregoing, the Baxter Investment Committee shall determine the initial investment funds available under the Baxalta IIP, and Baxter shall
provide all Transferred Employees with all blackout notices, and comply with all other requirements necessary to transfer the accounts of participants in the Baxter IIP to the Baxalta IIP. For all periods after the Distribution Date, the Parties
agree that the applicable fiduciaries of each of the Baxter IIP and the Baxalta IIP, respectively, shall have the authority with respect to the Baxter IIP and the Baxalta IIP, respectively, to determine the investment alternatives, the terms and
conditions with respect to those investment alternatives and such other matters as are within the scope of their duties under ERISA Section 404. 

(g) No Loss of Unvested Benefits; No Distributions. The transfer of any Transferred Employee’s employment to the Baxalta Group
will not result in loss of that Transferred Employee’s unvested benefits under the Baxter IIP or the Baxalta IIP Plan and no Transferred Employee shall be entitled to a distribution of his or her benefit under the Baxter IIP as a result of such
transfer of employment. 
 (h) Puerto Rico Employees. Effective as of or before the Distribution Date, Baxalta shall establish a
defined contribution plan qualified under the Puerto Rico Internal Revenue Code for a new Puerto Rico (the “Baxalta SIP”). As of the Distribution Date, the terms of the Baxalta SIP shall be substantially similar to the terms of the
Baxter Healthcare of Puerto Rico Savings and Investment Plan (the “Baxter SIP”) as of the Distribution Date (except as described in Section 3.02(f), including the existence of different investment options). Transferred
Employees who are participants in the Baxter SIP shall have their accounts in the Baxter SIP fully vested as of the Transfer Date, and shall thereafter be treated as terminated vested participants for all purposes of the Baxter SIP. Such
participants shall be eligible to participate in the Baxalta SIP to the extent they were eligible to participate in the Baxter SIP as of the applicable Transfer Date, and receive credit for vesting purposes for all service credited for that purpose
under the Baxter SIP as of the applicable Transfer Date as if that service had been rendered to Baxalta. The provisions of Section 3.02(c) shall also apply to the Baxalta SIP, as applicable. 

Section 3.03 Supplemental Pension Plan 

(a) Establishment of Baxalta SERP. Effective as of or before the Pension Split Date, Baxalta shall establish the Baxalta SERP, with
terms and funding arrangements substantially similar to those of the Baxter SERP as of the Pension Split Date. 
 (b) Assumption of SERP
Liabilities and Transfer from Baxter SERP. Except as provided below, as of a Transferred Employee’s Pension Eligibility Date, Baxalta 

  
 23 

 
shall, and shall cause the Baxalta SERP to, assume all Liabilities for all obligations under the Baxter SERP for the benefits of such individual (and any other individual on whose behalf
Liabilities are transferred from the Baxter Pension Plan to the Baxalta Pension Plan under Section 3.01(b)(ii)) and his or her beneficiaries and/or alternate payees determined as of the applicable Transfer Date, and Baxter and the Baxter
SERP shall be relieved of all Liabilities for those benefits. 
 (c) Baxalta SERP Provisions. As of the Pension Split Date, the
Baxalta SERP shall provide that: 
 (i) Transferred Employees shall (A) be eligible to participate in the Baxalta SERP
to the extent they were eligible to participate in the Baxter SERP as of the applicable Pension Eligibility Date, and (B) receive credit for vesting, eligibility and benefit service for all service credited for those purposes under the Baxter
SERP as of the Pension Eligibility Date as if that service had been rendered to Baxalta (provided that in the event that any such Transferred Employee receives a distribution from the Baxter SERP, the value of such distribution shall be offset
against future benefits under the Baxalta SERP to the extent necessary to avoid a duplication of benefits, the terms of such offset to be set forth in the Baxalta SERP); 

(ii) the compensation paid by the Baxter Group to a Transferred Employee that was recognized under the Baxter SERP as of the
Pension Eligibility Date shall be credited and recognized for all applicable purposes under the Baxalta SERP as though it were compensation from the Baxalta Group; 

(iii) the accrued benefit of each Transferred Employee under the Baxter SERP as of the applicable Pension Eligibility Date
shall be payable under the Baxalta SERP at the same time and in the same form that would have been paid under the Baxter SERP, treating such Transferred Employee’s separation from service from the Baxalta Group as if it were a separation from
service from the Baxter Group, taking into account any election made by the Transferred Employee relating to the time and form of his or her payment under the Baxter SERP; provided, however, that if a participant in the Baxter Pension
Plan who is scheduled to become a Transferred Employee terminates employment after the Pension Split Date, but before such participant’s Transfer Date, and the Pension Plan benefit of such participant is transferred back to the Baxter Pension
Plan pursuant to Section 3.01(b)(iii), the accrued benefit of such participant shall be paid exclusively by the Baxter SERP and shall be calculated as if such participant had been employed continuously by the Baxter Group through such
participant’s date of termination; 
 (iv) the Baxalta SERP shall assume and honor the terms of all arrangements
relating to beneficiaries in effect and honored under the Baxter SERP as of the applicable Transfer Date with respect to Transferred Employees; and 

(v) the Baxalta SERP shall provide the additional benefit accruals, if any, required by USERRA for a Former Employee who is
employed by the Baxalta Group following the Distribution Date pursuant to Section 2.02(a)(i)(C), including any amount that relates to the period of military leave that occurred prior to the Distribution Date. 

  
 24 

 (d) Baxter SERP after Transfer Date. From and after a Transferred Employee’s Pension
Eligibility Date, such Transferred Employee shall not participate in or accrue any benefits under the Baxter SERP. Without limiting the generality of the foregoing, each Transferred Employee shall cease to participate in the Baxter SERP effective as
of the applicable Pension Eligibility Date, except as otherwise provided in Section 3.03(c)(iii). The Baxter SERP shall continue to be responsible for Liabilities in respect of Baxter Retained Employees, Former Employees and (until the
applicable Transfer Date) Post-Distribution Baxalta Employees and their beneficiaries. To the maximum extent permitted by Treasury Regulations Section 1.409A-1(h)(4), a Transferred Employee shall not be considered to have undergone a
“separation from service” for purposes of Code Section 409A and the Baxter SERP solely by reason of the Separation, and, following his or her Transfer Date, the determination of whether a Transferred Employee has incurred a separation
from service with respect to his or her benefit in the Baxalta SERP shall be based solely upon his performance of services for the Baxalta Group. 

Section 3.04 Deferred Compensation Plan. 

(a) Establishment of Baxalta DCP. Effective as of or before the Distribution Date, Baxalta shall establish the Baxalta DCP, with terms
comparable in the aggregate to those of the Baxter DCP as of the Distribution Date; provided that the investment options thereunder may be different than those available under the Baxter DCP. 

(b) Assumption of DCP Liabilities and Transfer from Baxter DCP. 

(i) As of a Transferred Employee’s Transfer Date, Baxalta shall, and shall cause the Baxalta DCP to, assume all
Liabilities for all obligations under the Baxter DCP for the benefits of such individual and his or her beneficiaries, determined as of the applicable Transfer Date, and Baxter and the Baxter DCP shall be relieved of all Liabilities for those
benefits. 
 (ii) As of or as soon as practicable after the applicable Transfer Date, the Parties shall cooperate to cause
the accounts of the applicable Transferred Employee participating in the Baxter DCP to be transferred to the Baxalta DCP. Baxalta shall (A) credit each such Transferred Employee’s account with (1) the amount deferred by such
individual into the Baxter DCP as of the applicable Transfer Date, plus (2) any employer contributions, whether vested or unvested, deemed to have been made in relation to the amount described in (1), including, in each case, any earnings
thereon, and (B) recognize and honor all deferral and distribution elections made by such individual (including any deferral election applicable to any bonus earned but not yet paid as of the applicable Transfer Date). 

(iii) The accrued benefit of each Transferred Employee under the Baxter DCP as of the applicable Transfer Date shall be
payable under the Baxalta DCP at the same time and in the same form that would have been paid under the Baxter 

  
 25 

 
DCP, treating such Transferred Employee’s separation from service from the Baxalta Group as if it were a separation from service from the Baxter Group, taking into account any election made
by the Transferred Employee relating to the time and form of his or her payment under the Baxter DCP. 
 (iv) Baxalta shall
credit to the account of each Transferred Employee in the Baxalta DCP who was a participant in the Baxter DCP immediately prior to the Transfer Date an amount equal to the Excess Matching Contributions and Employer Non-Matching Contributions (in
each case as defined in the Baxter DCP), to which such Transferred Employee would have been entitled had such Transferred Employee been employed by the Baxter Group throughout 2015, reduced by the amount of Excess Matching Contributions and Employer
Non-Matching Contributions credited to such Transferred Employee’s account in the Baxter DCP, and shall also make up any contributions required by USERRA for a Former Employee who is employed by the Baxalta Group following the Distribution Date
pursuant to Section 2.02(a)(i)(C), including any amount that relates to the period of military leave that occurred prior to the Distribution Date. 

(c) Baxter DCP after Transfer Date. From and after a Transferred Employee’s Transfer Date, such individual shall
not participate in or accrue any benefits under the Baxter DCP. Without limiting the generality of the foregoing, each Transferred Employee shall cease to participate in the Baxter DCP effective as of his or her Transfer Date. The Baxter
DCP shall continue to be responsible for Liabilities in respect of Baxter Retained Employees, Former Employees and (until the applicable Transfer Date) Post-Distribution Baxalta Employees and their
beneficiaries. To the maximum extent permitted by Treasury Regulations Section 1.409A-1(h)(4), a Transferred Employee shall not be considered to have undergone a “separation from service” for
purposes of Code Section 409A and the Baxter DCP solely by reason of the Separation, and, following his Transfer Date, the determination of whether a Transferred Employee has incurred a separation from service with respect to his or her benefit
in the Baxalta DCP shall be based solely upon his or her performance of services for the Baxalta Group. 
 ARTICLE IV 

NON-U.S. RETIREMENT PLANS 

Section 4.01 Establishment of Non-U.S. Retirement Plans and Transfers of Assets and Liabilities. Except as mutually agreed
upon by the Parties or required under this Article IV, effective as of or before the Distribution Date, Baxalta or its appropriate Affiliate will establish pension and retirement plans (whether defined contribution or defined benefit pension
plans) with terms that are reasonably comparable to those of the corresponding Non-U.S. Baxter Benefit Plan. For purposes of this Article IV, the term Non-U.S. Baxter Benefit Plan shall not include the
Baxter Puerto Rico Pension Plan or the Baxter SIP. 
 (a) Transfer of Non-U.S. Retirement Plan Assets and Liabilities. As soon as
practicable prior to, on or after the Distribution Date, except as otherwise provided in this Agreement, the Assets and Liabilities determined as of the date of the applicable local closing occurring prior to, on or after the Distribution Date (such
date, the “Applicable Closing Date”) 

  
 26 

 
under the corresponding Non-U.S. Baxter Benefit Plan attributable to Transferred Non-U.S. Employees (and, with respect to each of the countries or entities listed in Schedule 4.01(a),
Former Employees) who are participants in that plan, along with any other Assets and Liabilities that Baxalta agrees to assume with respect to such plan, shall be transferred to the applicable Non-U.S. Baxalta Benefit Plan. The Non-U.S. Baxter
Benefit Plan shall retain all Assets and Liabilities related to Baxter Retained Employees, Former Employees (other than Former Employees in the countries or of the entities listed in Schedule 4.01(a)) and Post-Distribution Baxalta Employees
(subject to Section 4.01(c)), and with respect to all countries and entities set forth in Schedule 4.02(a) in accordance with Section 4.02(a). Assets will be allocated between the plans based on the proportion of
Liabilities borne by each plan. Except as otherwise mutually agreed upon by the Parties, such Liabilities will be valued using the projected benefit obligation based on plan provisions as in effect at the Applicable Closing Date and applying
demographic and other assumptions used in the most recently completed valuation of the applicable Non-U.S. Baxter Benefit Plan (and taking into account the requirements of ASC 715 as it exists as of the Applicable Closing Date); provided,
however, that all economic assumptions will be updated as of the Applicable Closing Date. The transfer amount described above shall be credited or debited, as applicable, with a pro rata share of the actual investment earnings or losses
allocable to the transfer amount for the period between the Applicable Closing Date and an assessment date set by Baxter that is as close as practicable, taking into account the timing and reporting of valuation of the applicable Non-U.S. Baxter
Benefit Plan’s Assets, to the date upon which Assets equal in value to the transfer amount are actually transferred from the applicable Non-U.S. Baxter Benefit Plan to the applicable Non-U.S. Baxalta Benefit Plan; provided that, if
actual investment earnings or losses are not then determinable, Baxter and Baxalta shall then agree on a reasonable alternative methodology (which may include expected or estimated returns used for other similar purposes by Baxter in the ordinary
course of business). During this period, benefits payable to Transferred Non-U.S. Employees (and, with respect to those countries or entities listed in Schedule 4.01(a), Former Employees) shall be paid from the Non-U.S. Baxter Benefit Plan.
Except as otherwise mutually agreed upon by the Parties, the ultimate transfer amount shall be reduced by the amount of these benefits and credited or debited by the actual investment earnings or losses from the payment date to the assessment date
set by Baxter above. Any third party fees, costs or expenses incurred under the applicable Non-U.S. Baxter Benefit Plan during the period from the Applicable Closing Date to the assessment date set by Baxter shall be shared by the Parties based on
the proportion of Liabilities borne by the applicable Non-U.S. Baxter Benefit Plan and the applicable Non-U.S. Baxalta Benefit Plan. The Parties agree to use commercially reasonable efforts to accomplish each transfer as soon as practicable on or
following the Applicable Closing Date and to cooperate with each other to make such filings and disclosures and obtain such approvals as may be deemed necessary or advisable in accordance with applicable Law. Notwithstanding the foregoing, to the
extent a Non-U.S. Baxter Benefit Plan is not required to be funded by applicable Law or is not voluntarily funded, there shall be no transfer of Assets by the Non-U.S. Baxter Benefit Plan or by the Baxter Group in respect thereof. 

(b) Non-U.S. Baxalta Retirement Plan Provisions. Each Non-U.S. Baxalta Benefit Plan shall provide, except as otherwise provided in
this Agreement or local Conveyance and Assumption Instruments that: 
 (i) Transferred Non-U.S. Employees (and, with respect
to each of the countries or entities listed in Schedule 4.01(a), Former Employees) shall (A) be 

  
 27 

 
eligible to participate in the Non-U.S. Baxalta Benefit Plan to the extent they were eligible to participate in the corresponding Non-U.S. Baxter Benefit Plan, and (B) receive credit for
vesting, eligibility and benefit service to the same extent recognized by Baxter as of immediately prior to the Transfer Date for all service credited for those purposes under the corresponding Non-U.S. Baxter Benefit Plan as if that service had
been rendered to Baxalta; 
 (ii) the compensation paid by the Baxter Group to a Transferred Non-U.S. Employee (or, with
respect to each of the countries or entities listed in Schedule 4.01(a), a Former Employee) that is recognized under the Non-U.S. Baxter Benefit Plan shall be credited and recognized for all applicable purposes under the corresponding
Non-U.S. Baxalta Benefit Plan as though it were compensation from the Baxalta Group; and 
 (iii) the accrued benefit of
each Transferred Non-U.S. Employee (or, with respect to each of the countries or entities listed in Schedule 4.01(a), each Former Employee) under the Non-U.S. Baxter Benefit Plan that is transferred to the corresponding Non-U.S. Baxalta
Benefit Plan pursuant to Section 4.01(a) shall be paid under such Non-U.S. Baxalta Benefit Plan in accordance with the terms of such Non-U.S. Baxalta Benefit Plan and applicable Law, with employment by the Baxter Group treated as
employment by the Baxalta Group under the Non-U.S. Baxalta Benefit Plan for purposes of determining eligibility for optional forms of benefit, early retirement benefits, or other benefit forms. 

(c) Subsequent Transfers. Periodically, at such times as agreed upon by the Parties after the initial transfer described in
Section 4.01(a), Baxalta shall cause the applicable Non-U.S. Baxalta Benefit Plan to receive Assets and assume all Liabilities under the applicable Non-U.S. Baxter Benefit Plan for Post-Distribution Baxalta Employees who become
Transferred Employees (including Assets and Liabilities in respect of beneficiaries and/or alternate payees) and the applicable Non-U.S. Baxter Benefit Plan shall transfer all such Assets and be relieved of such Liabilities. The amount of such
Assets to be transferred shall be determined as provided in Section 4.01(a) (and shall include any employee contributions made by such Post-Distribution Baxalta Employee between the Distribution Date and the applicable Transfer Date) and
shall be subject to the applicable provisions of Section 4.01(a). 
 (d) Notwithstanding the foregoing, if pension benefits are
funded by individually linked insurance contracts, such contracts in respect of Transferred Employees shall be assigned to Baxalta or its applicable Subsidiary in lieu of the transfers of (and calculations of value with respect to) other Assets
otherwise contemplated hereby. 
 Section 4.02 Shared Plan Model. 

(a) Baxalta Participation in Non-U.S. Baxter Retirement Plans. 

(i) In each of the countries or entities listed in Schedule 4.02(a), Baxter or its appropriate Affiliate will permit
Baxalta or its appropriate Affiliate to continue to participate in the Non-U.S. Baxter Benefit Plan providing retirement 

  
 28 

 
benefits in that country after the Distribution. Except as otherwise mutually agreed upon by the Parties, such continued participation is subject to the following requirements: (A) Baxter or
its appropriate Affiliate will remain the principal employer under the plan; (B) the applicable Baxter pension fund (or such other party or parties have such amendment rights under the terms of the applicable plan, if any) may amend the plan at
any time; (C) any third party fees, costs or expenses shall be shared by the Parties on the basis of their proportionate share of the insured salaries under the Non-U.S. Baxter Benefit Plan; (D) Baxter shall determine the benefit formula
or structure under the plan (which shall apply uniformly to all similarly situated participants); and (E) such continued participation may not extend beyond two years after the Distribution Date, unless otherwise mutually agreed by each
Party’s CVP of Human Resources (or such individual’s delegate). 
 (ii) At or before the end of the shared plan
period, in each of the countries or entities listed in Schedule 4.02(a), Baxalta or its appropriate Affiliate shall establish its own plan or arrangement to deliver the benefits due to Baxalta Employees (and, with respect to each of the
countries or entities marked with an asterisk in Schedule 4.02(a), Former Employees) under the applicable Non-U.S. Baxter Benefit Plan or otherwise shall be responsible for all costs incurred by the Parties in connection with winding up or
terminating the participation of Baxalta or its appropriate Affiliate in the Non-U.S. Baxter Benefit Plan. Following the establishment of the Non-U.S. Baxalta Benefit Plan, the Assets and Liabilities of the Non-U.S. Baxter Benefit Plan attributable
to Baxalta Employees (and, with respect to each of the countries or entities marked with an asterisk in Schedule 4.02(a), Former Employees) who are participants in that plan shall be transferred to the applicable Non-U.S. Baxalta Benefit
Plan. Assets will be allocated between the plans based on the proportion of Liabilities borne by each plan. Except as otherwise mutually agreed upon by the Parties, such Liabilities will be valued as of the Shared Plan Replacement Date using the
projected unit credit method based on plan provisions as in effect at the Shared Plan Replacement Date and applying the demographic and other assumptions used in the most recently completed valuation of the applicable Non-U.S. Baxter Benefit Plan
(and taking into account the requirements of ASC 715 as it exists as of the Shared Plan Replacement Date); provided, however, that all economic assumptions will be updated as of the Shared Plan Replacement Date. The transfer amount
described above shall be credited or debited, as applicable, with a pro rata share of the actual investment earnings or losses allocable to the transfer amount for the period between the Shared Plan Replacement Date and an assessment date set by
Baxter that is as close as practicable, taking into account the timing and reporting of valuation of the applicable Non-U.S. Baxter Benefit Plan’s Assets, to the date upon which Assets equal in value to the transfer amount are actually
transferred from the applicable Non-U.S. Baxter Benefit Plan to the applicable Non-U.S. Baxalta Benefit Plan; provided that, if actual investment earnings or losses are not then determinable, Baxter and Baxalta shall then agree on a
reasonable alternative methodology (which may include expected or estimated returns used for other similar purposes by Baxter in the ordinary course of business). During this period, benefits payable to Baxalta Employees (and, with respect to each
of the countries or entities marked with an asterisk in Schedule 4.02(a), Former Employees) shall be paid from the Non-U.S. Baxter Benefit Plan. Except as otherwise mutually agreed upon by the Parties, the ultimate transfer amount shall be
reduced by the amount of these benefits and credited or debited by the actual investment 

  
 29 

 
earnings or losses from the payment date to the assessment date set by Baxter above. Any third party fees, costs or expenses incurred under the applicable Non-U.S. Baxter Benefit Plan during the
period from the Shared Plan Replacement Date to the assessment date set by Baxter shall be shared by the Parties on the basis of their proportionate share of the insured salaries under the Non-U.S. Baxter Benefit Plan. The Parties agree to use
commercially reasonable efforts to accomplish each transfer as soon as practicable following the Shared Plan Replacement Date and to cooperate with each other to make such filings and disclosures and obtain such approvals as may be deemed necessary
or advisable in accordance with applicable Law. Such transfers and any actuarial assumptions shall be subject to such minimum consents, approvals and other legal requirements as may apply under applicable Law, including, if required, the consent of
any affected plan participant or any other third party. Notwithstanding the foregoing, to the extent a Non-U.S. Baxter Benefit Plan is not required to be funded by applicable Law or is not voluntarily funded, there shall be no transfer of Assets by
the Non-U.S. Baxter Benefit Plan or by the Baxter Group in respect thereof. 
 (b) Non-U.S. Baxter Retirement Plan Provisions. Each
Non-U.S. Baxter Benefit Plan described in Section 4.02(a) shall provide, except as otherwise provided in this Agreement, that: 

(i) Baxalta Employees (and, with respect to each of the countries or entities marked with an asterisk in Schedule
4.02(a), Former Employees) shall (A) be eligible to participate in the Non-U.S. Baxter Benefit Plan to the extent they were eligible to participate in such plan immediately prior to the Distribution Date, and (B) receive credit for
vesting, eligibility and benefit service for all service with the Baxalta Group during the shared plan period as if that service had been rendered to Baxter; 

(ii) the compensation paid by the Baxalta Group to a Baxalta Employee (and, with respect to each of the countries or entities
marked with an asterisk in Schedule 4.02(a), a Former Employee) during the shared plan period shall be credited and recognized for all applicable purposes under the corresponding Non-U.S. Baxter Benefit Plan as though it were compensation
from the Baxter Group; and 
 (iii) the accrued benefit of each Baxalta Employee (and, with respect to each of the countries
or entities marked with an asterisk in Schedule 4.02(a), Former Employee) under the Non-U.S. Baxter Benefit Plan shall be paid at the time and in a form provided under such plan, with employment by the Baxalta Group during the shared plan
period treated as employment by the Baxter Group under the Non-U.S. Baxter Benefit Plan for purposes of determining eligibility for optional forms of benefit, early retirement benefits, or other benefit forms. 

(c) Subsequent Transfers. Periodically, at such times as agreed upon by the Parties after the initial transfer described in
Section 4.02(a), Baxalta shall cause the applicable Non-U.S. Baxalta Benefit Plan to receive Assets and assume all Liabilities under the applicable Non-U.S. Baxter Benefit Plan for Post-Distribution Baxalta Employees (and, with respect
to each of the countries or entities marked with an asterisk in Schedule 4.02(a), Former 

  
 30 

 
Employees) who become Transferred Employees (including Assets and Liabilities in respect of beneficiaries and/or alternate payees) and the applicable Non-U.S. Baxter Benefit Plan shall transfer
all such Assets and be relieved of such Liabilities. The amount of such Assets to be transferred shall be determined as provided in Section 4.02(a) (and shall include any employee contributions made by such Post-Distribution Baxalta
Employee between the Distribution Date and the applicable Transfer Date) and shall be subject to the applicable provisions of Section 4.02(a). 

ARTICLE V 
 WELFARE AND
FRINGE BENEFIT PLANS 
 Section 5.01 Health and Welfare Plans. 

(a) Establishment of Baxalta Health and Welfare Plans. Effective as of or before the Distribution Date, Baxalta shall establish the
Baxalta Health and Welfare Plans, with terms comparable in the aggregate to those of the corresponding Baxter Health and Welfare Plans as of the Distribution Date unless otherwise provided in this Article V. 

(b) Waiver of Conditions; Benefit Maximums. Baxalta shall, to the extent commercially reasonable and permitted under applicable Law
and, with respect to Non-U.S. Health and Welfare Plans, to the extent applicable, cause the Baxalta Health and Welfare Plans to: 

(i) with respect to initial enrollment (whether passive or active) prior to, as of or following the applicable Transfer Date,
waive: 
 (A) all limitations as to preexisting conditions, exclusions, and service conditions with respect to participation
and coverage requirements applicable to any Transferred Employee, other than limitations that were in effect with respect to the Transferred Employee under the applicable Baxter Health and Welfare Plan as of immediately prior to such
individual’s Transfer Date, and 
 (B) any waiting period limitation or evidence of insurability requirement applicable
to a Transferred Employee other than limitations or requirements that were in effect with respect to such Transferred Employee under the applicable Baxter Health and Welfare Plan as of immediately prior to such individual’s Transfer Date; and

 (ii) take into account: 

(A) with respect to aggregate annual, lifetime, or similar maximum benefits available under the Baxalta Health and Welfare
Plans, a Transferred Employee’s prior claim experience under the Baxter Health and Welfare Plans and any Benefit Plan that provides leave benefits; and 

  
 31 

 (B) any eligible expenses incurred by a Transferred Employee and his or her
covered dependents during the portion of the plan year of the applicable Baxter Health and Welfare Plan ending on the applicable Transfer Date to be taken into account under such Baxalta Health and Welfare Plan for purposes of satisfying all
deductible, coinsurance, and maximum out-of-pocket requirements applicable to such Transferred Employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such Baxalta Health and
Welfare Plan. 
 (c) Allocation of Health and Welfare Assets and Liabilities. 

(i) General Principles. Notwithstanding any other provision hereof and except as otherwise agreed between the Parties,
(A) Baxter shall retain all Liabilities relating to Incurred Claims of Baxter Retained Employees and Former Employees under the Baxter Health and Welfare Plans, and shall also retain Assets (including, without limitation, Medicare
reimbursements, pharmaceutical rebates, and similar items) associated with such Incurred Claims and (b) Baxalta shall be responsible for Incurred Claims of Baxalta Employees from and after the applicable Transfer Date. Baxalta shall be
responsible for all Liabilities relating to Incurred Claims under any Baxalta Health and Welfare Plan and shall also retain Assets (including, without limitation, Medicare reimbursements, pharmaceutical rebates, and similar items) associated with
such Incurred Claims. 
 (ii) Disability Benefits. Notwithstanding any other provision hereof and except as otherwise
agreed between the Parties, (A) Baxter shall be responsible for Incurred Claims (including ongoing benefit payments) of Baxter Retained Employees and Former Employees for short- and long-term disability benefits, regardless of when the
applicable Incurred Claim was incurred and (B) subject to the immediately following sentence, Baxalta shall be responsible for Incurred Claims (including ongoing benefit payments) of Baxalta Employees from and after the applicable Transfer Date
for short-term disability benefits and long-term disability benefits. Notwithstanding the foregoing, a Baxalta Employee who is on short-term disability leave on the Transfer Date and who subsequently qualifies for long-term disability without an
intervening new Incurred Claim shall receive long-term disability benefits from the Baxter long-term disability plan, but all other benefits attributable to his or her disability (including continued pension accrual, if applicable, and participation
in any medical or life insurance plan for disabled persons) shall be provided by the applicable Baxalta Benefit Plan, if any, or otherwise be the responsibility of Baxalta, and if Baxalta does not sponsor a plan providing any such benefits, such
Baxalta Employee shall not be entitled to such benefits from any Baxter Benefit Plan. 
 (iii) Flexible Spending
Accounts. Except as set forth on Schedule 5.01(c)(iii), the Parties shall take all actions necessary to ensure that, effective as of the Distribution Date (or, if later, the Transfer Date applicable to a Post-Distribution Baxalta
Employee), (A) the health care and dependent care flexible spending accounts of Transferred Employees (whether positive or negative) (the “Transferred Flexible 

  
 32 

 
Spending Account Balances”) under the applicable Baxter Health and Welfare Plan shall be transferred to the corresponding Baxalta Health and Welfare Plan; (B) the elections,
contribution levels and coverage of the applicable Transferred Employees shall apply under the Baxalta Health and Welfare Plan in the same manner as under the corresponding Baxter Health and Welfare Plan; and (C) the applicable Transferred
Employees shall be eligible for reimbursement from the Baxalta Health and Welfare Plan on the same basis and the same terms and conditions as under the corresponding Baxter Health and Welfare Plan. As soon as practicable after the Distribution Date,
and in any event within 30 business days after the amount of the Transferred Flexible Spending Account Balances is determined, Baxter shall pay Baxalta the net aggregate amount of the Transferred Flexible Spending Account Balances, if such amount is
positive, and Baxalta shall pay Baxter the net aggregate amount of the Transferred Flexible Spending Account Balances, if such amount is negative. 

(d) Retiree Health Care Plan and Retiree Life Insurance. Notwithstanding any other provision hereof (or any other action taken by
Baxter and Baxalta on or prior to the Distribution Date, including any assignment and assumption of Assets or Liabilities related thereto), Baxter shall retain the Liabilities and responsibility for all obligations under the Baxter Retiree Health
Care Plan and the Baxter Health and Welfare Plan (solely with respect to life insurance benefits in the case of the Baxter Health and Welfare Plan) for benefits due to Baxter Retained Employees and Former Employees, and shall also retain Assets,
including, without limitation, Medicare reimbursements, pharmaceutical rebates, and similar items, associated with such benefits. Effective as of or before the Distribution Date, Baxalta shall establish a health care plan for retirees, with terms
comparable in the aggregate to the Baxter International Inc. Welfare Plan for Retirees and Disabled Individuals, provided that the Baxalta Plan shall not be required to provide any benefits previously provided by the Baxter International Inc. and
Subsidiaries Medical and Dental Plan for Disabled Individuals prior to its merger into the Baxter International Inc. Welfare Plan for Retirees and Disabled Individuals. 

(e) Baxter Health and Welfare Plans after Distribution Date. Transferred Employees shall cease to participate in the Baxter Health and
Welfare Plans effective as of their respective Transfer Dates. 
 (f) Shared Health and Welfare Plans. To the extent that, following
the Distribution Date, there is any Non-U.S. Health and Welfare Plan pursuant to which health and welfare benefits are provided to Employees of both the Baxter Group and the Baxalta Group, the Parties or their appropriate Affiliates shall share the
costs for such shared plan, except as otherwise mutually agreed upon by the Parties. Any Baxter Affiliate or Baxalta Affiliate may withdraw from or otherwise cease to participate in any such shared plan following the Distribution Date upon at least
90 days’ advance written notice to the other participating employer(s) of such withdrawal or cessation. 
 (g) Multi-National
Pooling Arrangements. For purposes of this provision, the term “multi-national pooling arrangement” means a contract or arrangement that facilitates the purchase or provision of employee benefits. Baxter shall retain all Assets
(including, without limitation, rights to dividends and similar items) with respect to employee benefits-related pooling contracts to which any member of the Baxter Group is a party or under 

  
 33 

 
which any member of the Baxter Group pays the premiums. From and after the Distribution Date, Baxalta shall retain all Assets (including, without limitation, rights to dividends and similar
items) with respect to employee benefits-related pooling contracts to which any member of the Baxalta Group is a party or under which any member of the Baxalta Group pays the premiums. 

(h) Life Insurance Premium Reserve Refund. The Parties acknowledge and agree that a cash payment in respect of surplus life insurance
premiums paid prior to the Distribution Date is expected to be received by the Baxter Group in late 2015 or early 2016. Promptly following the Baxter Group’s receipt of any such amounts, Baxter shall notify Baxalta of the amount of such payment
attributable to employee-paid premiums with respect to Transferred Employees and shall promptly pay such amounts to the account or accounts directed by Baxalta and Baxalta shall use such amounts for the benefit of the applicable employees (whether
through a premium holiday, reduced premiums or otherwise). 
 Section 5.02 COBRA and HIPAA. Baxter shall continue to be
responsible for compliance with the health care continuation requirements of COBRA, the certificate of creditable coverage requirements of HIPAA, and the corresponding provisions of the Baxter Health and Welfare Plans with respect to any
(a) Baxter Retained Employees and any Former Employees (and their covered dependents) who incur a qualifying event under COBRA on, prior to, or following the Distribution Date, (b) Baxalta Employees who do not at any time become
Transferred Employees (and their covered dependents) who incur a qualifying event under COBRA on, prior to, or following the Distribution Date, and (c) other Baxalta Employees (and their covered dependents), with respect to qualifying events
under COBRA incurred prior to or on the applicable Transfer Date. Baxalta shall assume responsibility for compliance with the health care continuation requirements of COBRA, the certificate of creditable coverage requirements of HIPAA, and the
corresponding provisions of the Baxalta Health and Welfare Plans with respect to any Transferred Employees (and their covered dependents) who incur a qualifying event or loss of coverage under the Baxalta Health and Welfare Plans after their
respective Transfer Dates. The Parties agree that the consummation of the transactions contemplated by the Separation and Distribution Agreement shall not constitute a COBRA qualifying event for any purpose of COBRA. 

Section 5.03 Vacation, Holidays and Leaves of Absence. Effective as of the applicable Transfer Date in accordance with
Section 2.01(a)(i), Baxalta shall be responsible for any and all Liabilities to, or relating to, Transferred Employees in respect of vacation, holiday, personal days, sick days, annual leave or other leave of absence, and required
payments related thereto. Baxter shall retain all Liabilities with respect to vacation, holiday, annual leave or other leave of absence, and required payments related thereto, for each Baxter Retained Employee and Former Employee, as well as Baxalta
Employees until the applicable Transfer Date of such Baxalta Employees. 
 Section 5.04 Severance and Unemployment
Compensation. Effective as of the applicable Transfer Date, Baxalta shall be responsible for any and all Liabilities to, or relating to, Transferred Employees in respect of severance and unemployment compensation. Subject to any
specific agreement to the contrary in the Separation and Distribution Agreement or any Ancillary Agreement and subject to Section 2.02(a)(ii), Baxter shall be responsible for any and all Liabilities to, or relating to, Baxter Retained
Employees and Former Employees, as 

  
 34 

 
well as Baxalta Employees until an applicable Transfer Date occurs with respect to such Baxalta Employees, in respect of severance and unemployment compensation, regardless of whether the event
giving rise to the Liability occurred prior to, on, or following the Distribution Date. In the event that an employee receiving severance pay under the Baxter severance plan is hired by Baxalta, the remaining severance payable to the employee under
the terms of the Baxter severance plan, if any, shall be paid in a single lump sum to the extent permitted by Code Section 409A and, if not so permitted, shall be forfeited. 

Section 5.05 Workers’ Compensation. Except as required by applicable Law or as otherwise determined jointly by the
Parties as a result of the requirements of any Governmental Authority, all United States workers’ compensation Liabilities relating to, arising out of, or resulting from any claim (a) by Employees designated internally as working for or
assigned to the BioScience or BioLife commercial units, to the extent such claim was incurred prior to May 1, 2015, shall be assumed, or retained as the case may be, by Baxalta as of the Transfer Date or (b) incurred on or after
May 1, 2015 shall be assumed, or retained as the case may be, by the Party (or its applicable Subsidiary) that employed such Employee as of the time of such claim. The Baxter Group shall be responsible for all Liabilities relating to, arising
out of, or resulting from any United States workers’ compensation claims incurred prior to May 1, 2015 unless expressly specified otherwise in the immediately preceding sentence or as required by applicable Law. Each member of the Baxalta
Group and the Baxter Group shall cooperate with respect to any notification to appropriate governmental agencies of the disposition and the issuance of new, or the transfer of existing, workers’ compensation insurance policies and claims
handling contracts. 
 ARTICLE VI 

EQUITY, INCENTIVE, AND DIRECTOR AND EXECUTIVE COMPENSATION PROGRAMS 

Section 6.01 Equity Incentive Programs. 

(a) Options, PSUs and RSUs. The Parties shall use commercially reasonable efforts to take all actions necessary or appropriate so that
each outstanding Baxter Option, Baxter PSU Award, or Baxter RSU Award granted under a Baxter Stock Program shall be adjusted or converted as set forth in this Section 6.01. This Section 6.01(a) shall not apply to grants
(including those Baxter RSU Awards deferred pursuant to the Baxter Directors’ DCP) made under the Baxter Directors’ Plan (or any successor or predecessor plan), and the sole provisions with respect to the adjustment and conversion of those
grants are set forth in Section 6.04. 
 (i) Baxter Options. As determined by the Baxter Compensation
Committee pursuant to its authority under the applicable Baxter Stock Program, each Baxter Option granted prior to January 1, 2015 (other than new hire grants made on or after July 1, 2014) that remains outstanding as of immediately prior
to the Distribution Date, regardless of by whom held, whether vested or unvested, shall be converted concurrently with the Distribution on the Distribution Date into both an Adjusted Baxter Option and a Baxalta Option. As determined by the Baxter

  
 35 

 
Compensation Committee pursuant to its authority under the applicable Baxter Stock Program, each Baxter Option granted on or after January 1, 2015 (or, with respect to new hire grants, on or
after July 1, 2014), but prior to the Distribution Date that remains outstanding as of immediately prior to the Distribution Date, regardless of by whom held, whether vested or unvested, shall be converted concurrently with the Distribution on
the Distribution Date into (x) an Adjusted Baxter Option in the case of Baxter Employees and Baxter Former Employees or (y) a Baxalta Option in the case of Baxalta Employees or Baxalta Former Employees. Each such adjusted or converted
Option shall, except as otherwise provided in this Section 6.01, be subject to the same terms and conditions (including with respect to vesting) after the Distribution Date as applicable to such Baxter Option immediately prior to the
Distribution Date; provided, however, that upon such adjustment or conversion: 
 (A) with respect to each
Baxter Option granted prior to January 1, 2015 (other than new hire grants made on or after July 1, 2014), the number of Baxter Common Shares subject to such Option shall be unchanged from the number of Baxter Common Shares that were
subject to the original unadjusted Baxter Option; 
 (B) with respect to each Baxter Option granted prior to January 1,
2015 (other than new hire grants made on or after July 1, 2014), the number of shares of Baxalta Common Stock subject to the Baxalta Option issued with respect to such Option, rounded down to the nearest whole share, shall be equal to the
product obtained by multiplying (1) the number of Baxter Common Shares subject to the Baxter Option immediately prior to the Distribution Date times (2) the Distribution Ratio; 

(C) with respect to each Baxter Option granted on or after January 1, 2015 (or, with respect to new hire grants, on or
after July 1, 2014), the number of Baxter Common Shares subject to such Adjusted Baxter Option (if any), rounded down to the nearest whole number, shall be equal to the (1) the number of Baxter Common Shares subject to the Baxter Option
immediately prior to the Distribution Date, divided by (2) the Baxter Percentage; 
 (D) with respect to each Baxter
Option granted on or after January 1, 2015 (or, with respect to new hire grants, on or after July 1, 2014), the number of shares of Baxalta Common Stock subject to the Baxalta Option into which such Baxter Option is converted (if any),
rounded down to the nearest whole number, shall be equal to (1) the product obtained by multiplying (xx) the number of Baxter Common Shares subject to the Baxter Option immediately prior to the Distribution Date times (yy) the Distribution
Ratio, divided by (2) the Baxalta Percentage; 
 (E) the per share exercise price of each Adjusted Baxter Option,
rounded up to the nearest hundredth of a cent, shall be equal to (1) the Baxter Pre-Distribution Stock Value minus (2) the Baxter Pre-Distribution Option Value; and 

  
 36 

 (F) the per share exercise price of each Baxalta Option, rounded up to the
nearest hundredth of a cent, shall be equal to (1) the Baxalta Stock Value minus (2) the Baxalta Pre-Distribution Option Value; 

provided, however, that the exercise price, the number of Baxter Common Shares and shares of Baxalta Common Stock subject to such options, and
the terms and conditions of exercise of such options shall be determined in a manner consistent with the requirements of Code Section 409A; provided, further, that, in the case of any Baxter Option to which Code Section 421
applies by reason of its qualification under Code Section 422 as of immediately prior to the Distribution Date, the exercise price, the number of Baxter Common Shares and shares of Baxalta Common Stock subject to such option, and the terms and
conditions of exercise of such option shall be determined in a manner consistent with the requirements of Code Section 424(a). 

(ii) Baxter PSU Awards. As determined by the Baxter Compensation Committee pursuant to its authority under the
applicable Baxter Stock Program, prior to the Distribution Date, Baxter shall, notwithstanding the existing terms of such awards, cause such Baxter Awards to be equitably adjusted. Each Baxter PSU Award granted prior to January 1, 2015
that remains outstanding as of immediately prior to the Distribution Date shall be converted (regardless of by whom held, and whether or not vested or unvested) into (A) a number of Baxter Awards equal to the number of Baxter Common Shares
payable in respect of such Baxter Award and (B) a number of Baxalta Awards equal to the product obtained by multiplying (1) the number of Baxter Common Shares payable in respect of such Baxter PSU Award times (2) the Distribution
Ratio, in each case as determined by Baxter’s Compensation Committee. The Baxter Awards and Baxalta Awards received upon conversion of Baxter PSU Awards in accordance with this Section 6.01(a)(ii) both shall be subject to
substantially the same terms and conditions (including with respect to vesting) immediately following the Distribution Date as applicable immediately prior to the Distribution Date for those Baxter Awards from which such Baxter Awards and Baxalta
Awards were converted. 
 (iii) Baxter RSU Awards. Each holder of Baxter RSU Awards granted prior to January 1,
2015 (other than new hire grants made on or after July 1, 2014) that remain outstanding as of immediately prior to the Distribution Date, regardless of by whom held, whether vested or unvested, shall receive (in addition to retaining such
Baxter RSU Awards) concurrently with the Distribution on the Distribution Date a number of Baxalta RSU Awards equal to the product obtained by multiplying (x) the number of such Baxter RSU Awards held by such holder times (y) the
Distribution Ratio. Each Baxter RSU Award granted on or after January 1, 2015 (or, with respect to new hire grants, on or after July 1, 2014) but prior to the Distribution Date that remains outstanding as of immediately prior to the
Distribution Date, regardless of by whom held, whether vested or unvested, shall be converted concurrently with the Distribution on the Distribution Date into (A) an Adjusted Baxter RSU Award in the case of Baxter Employees and Baxter Former
Employees or (B) a Baxalta RSU Award in the case of Baxalta Employees or Baxalta Former Employees. Except as set forth in this Section 6.01(a)(iii), 

  
 37 

 
all Adjusted Baxter RSU Awards and Baxalta RSU Awards issued in accordance with this Section 6.01(a)(iii) shall be subject to substantially the same terms and conditions (including
with respect to vesting) immediately following the Distribution Date as applicable immediately prior to the Distribution Date for those Baxter RSU Awards from which such Adjusted Baxter RSU Awards and Baxalta RSU Awards were converted;
provided, however, that with respect to each Baxter RSU Award granted on or after January 1, 2015 (or, with respect to new hire grants, on or after July 1, 2014): 

(A) the number of units represented by an Adjusted Baxter RSU Award shall be equal to (1) the number of units subject to
the Baxter RSU Award immediately prior to the Distribution Date, divided by (2) the Baxter Percentage; 
 (B) the
number of units represented by a Baxalta RSU Award shall be equal to (1) the product obtained by multiplying (xx) the number of units subject to the Baxter RSU Award immediately prior to the Distribution Date times (yy) the Distribution
Ratio, divided by (2) the Baxalta Percentage. 
 (iv) Notwithstanding the foregoing, the Parties may mutually agree not
to adjust (or to otherwise adjust as they deem appropriate) certain outstanding Baxter equity-based awards pursuant to the foregoing provisions of this Section 6.01 to the extent such actions would create or trigger adverse legal,
accounting or tax consequences or in order to comply with any Employee Agreement or similar agreement with any affected Employee. 
 (b)
Miscellaneous Award Terms. After the Distribution Date, Adjusted Baxter Awards, regardless of by whom held, shall be settled by Baxter, and Baxalta Awards, regardless of by whom held, shall be settled by Baxalta. Except as otherwise provided
in this Agreement, with respect to grants described in this Section 6.01, (i) no Transferred Employee shall be treated as having incurred a termination of employment with respect to any Baxter Award solely by reason of the transfer
of employment, (ii) employment with the Baxter Group shall be treated as employment with Baxalta with respect to Baxalta Awards held by Baxter Retained Employees, and (iii) employment with the Baxalta Group shall be treated as employment
with Baxter with respect to Adjusted Baxter Awards held by Baxalta Employees. In addition, neither the Separation nor the Distribution (including, for the avoidance of doubt, any Local Closing Transaction) shall constitute a termination of
employment for any Employee for purposes of any Adjusted Baxter Award or any Baxalta Award. Following the Distribution Date, for any award adjusted or otherwise received in accordance with this Section 6.01, any reference to a
“change in control,” “change of control” or similar definition in an award agreement, employment agreement or Baxter Stock Program applicable to such award (A) with respect to Adjusted Baxter Awards, shall be deemed to refer
to a “change in control,” “change of control” or similar definition as set forth in the applicable award agreement, employment agreement or Baxter Stock Program (a “Baxter Change of Control”), and (B) with
respect to Baxalta Awards, shall be deemed to refer to a “change in control,” “change of control” or similar definition as defined in the Baxalta Equity Plan (a “Baxalta Change of Control”). Without limiting the
foregoing, with respect to provisions related to vesting of awards, a Baxter Change of Control 

  
 38 

 
shall be treated as a Baxalta Change of Control for purposes of Baxalta Awards held by Baxter Retained Employees or Baxter Former Employees, and a Baxalta Change of Control shall be treated as a
Baxter Change of Control for purposes of Adjusted Baxter Awards held by Baxalta Employees or Baxalta Former Employees. The Distribution shall not, in and of itself, be treated as either a Baxter Change of Control or a Baxalta Change of Control 

(c) Tax Reporting and Withholding. Following the Distribution Date, it is generally expected that (i) Baxter will be responsible
for all income, payroll and other tax remittance and reporting related to income of Baxter Retained Employees, Baxter Former Employees, and individuals who continue to be Baxter non-employee directors immediately following the Distribution Date in
respect of Adjusted Baxter Awards and Baxalta Awards; and (ii) Baxalta will be responsible for all income, payroll and other tax remittance and reporting related to income of Transferred Employees, Baxalta Former Employees and Baxalta
non-employee directors who do not continue to be Baxter non-employee directors immediately following the Distribution Date in respect of Adjusted Baxter Awards and Baxalta Awards. Baxter or Baxalta, as applicable, shall facilitate performance by the
other Party of its obligations hereunder by promptly remitting amounts or shares withheld in conjunction with a transfer of shares or cash, either (as mutually agreed by the Parties) directly to the applicable taxing authority or to the other Party
for remittance to such taxing authority. The Parties will cooperate and communicate with each other and with third-party providers to effectuate withholding and remittance of taxes, as well as required tax reporting, in a timely, efficient and
appropriate manner. Baxter and Baxalta shall, to the extent practicable, (x) treat Baxalta (or a member of the Baxalta Group designated by Baxter) as a “successor employer” and Baxter (or the appropriate member of the Baxter Group) as
a “predecessor,” within the meaning of Sections 3121(a)(1) and 3306(b)(1) of the Code, with respect to Baxalta Employees (upon the Transfer Date for such Baxalta Employee) for purposes of taxes imposed under the United States Federal
Unemployment Tax Act or the United States Federal Insurance Contributions Act, and (y) cooperate with each other to avoid, to the extent possible, the filing of more than one IRS Form W-2 with respect to each Baxalta Employee for the year in
which the Transfer Date for such Baxalta Employee occurs. The obligations to cooperate and support the other in respect of such tax withholding and remittance shall not continue beyond the termination or expiration of such or similar transition
services under the Transition Services Agreement. 
 (d) Registration and Other Regulatory Requirements. As soon as possible
following (or prior to) the Distribution Date, but in any case before the date of issuance of any shares of Baxalta Common Stock pursuant to the Baxalta Equity Plan, Baxalta agrees to file a Form S-8 Registration Statement (or such other
registration statement as may be permitted in lieu thereof if a Form S-8 Registration Statement is not then available for any such awards to be granted in accordance with the terms of this Agreement) with respect to, and to cause to be registered
pursuant to the Securities Act, the shares of Baxalta Common Stock authorized for issuance under the Baxalta Equity Plan as required pursuant to the Securities Act. The Parties shall take such additional actions as are deemed necessary or
advisable to effectuate the foregoing provisions of this Section 6.01, including compliance with securities Laws and other legal requirements associated with equity compensation awards in affected non-U.S. jurisdictions. Baxter agrees to
facilitate the adoption and approval of the Baxalta Equity Plan consistent with the requirements of Treasury Regulations Section 1.162-27(f)(4)(iii). 

  
 39 

 (e) Baxter Equity-Based Awards in Certain Non-U.S. Jurisdictions. Notwithstanding the
foregoing provisions of this Section 6.01, the Parties may mutually agree, in their sole discretion (including as set forth in Schedule 6.01(e)), not to adjust certain outstanding Baxter equity-based awards pursuant to the
foregoing provisions of this Section 6.01, where those actions would create or trigger adverse legal, accounting or tax consequences for Baxter, Baxalta, and/or the affected non-U.S. award holders. In such circumstances, Baxter and/or
Baxalta may take any action necessary or advisable to prevent any such adverse legal, accounting or tax consequences, including, but not limited to, agreeing that the outstanding Baxter equity-based awards of the affected non-U.S. award holders
shall terminate in accordance with the terms of the Baxter Stock Programs and the underlying award agreements, in which case Baxalta or Baxter, as applicable, shall equitably compensate the affected non-U.S. award holders in an alternate manner
determined by Baxalta or Baxter, as applicable, in its sole discretion, or apply an alternate adjustment method. Where and to the extent required by applicable Law or tax considerations outside the United States, the adjustments described in this
Section 6.01 shall be deemed to have been effectuated immediately prior to the Distribution Date. 
 Section 6.02
Employee Stock Purchase Plan. 
 (a) Baxter ESPP. The administrator of the Baxter ESPP shall take all actions necessary
and appropriate to provide that: (i) the final purchases to be made thereunder by Baxalta Employees may, subject to clause (iv), occur (and reasonable time is provided to allow such purchases to occur) before the applicable Transfer Date to
allow such participants to purchase Baxter Common Shares under the Baxter ESPP prior to such Transfer Date; (ii) all participant payroll deductions and other contributions under the Baxter ESPP by Baxalta Employees shall cease on or before the
final purchases by such Baxalta Employees pursuant to in clause (i) of this paragraph; (iii) subject to clause (iv), Baxalta Employees in the Baxter ESPP shall not be eligible to make any future purchases or participate in any future
Offerings (as defined in the Baxter ESPP) following the applicable Transfer Date; and (iv) any cash remaining in the Baxter ESPP account of any Baxalta Employee described in clause (iii) shall either be used to make purchases of Baxter
Common Shares under the Baxter ESPP as of the next regularly scheduled purchase date under the Baxter ESPP or, to the extent required under applicable local Law, refunded to such Baxalta Employee. For purposes of this paragraph, the administrator of
the Baxter ESPP may establish an alternate Offering End Date (as defined in the Baxter ESPP) for a sub-plan of the Baxter ESPP, as it determines to be necessary or advisable to accommodate the operation and administration of the sub-plan. 

(b) Establishment of Baxalta ESPP. Effective as of or before the Distribution Date, Baxalta shall establish the Baxalta ESPP, with
terms substantially similar to those of the Baxter ESPP as of the Distribution Date; provided, however, that Baxalta may delay implementation of the Baxalta ESPP or otherwise choose not to establish such Baxalta ESPP in one or more
countries (i) to the extent necessary to complete those actions and undertakings that Baxalta, in its sole discretion, determines to be necessary or advisable to comply with applicable Law or (ii) if Baxalta determines, in its sole
discretion, that establishing and maintaining such Baxalta ESPP in such country would not be commercially reasonable in light of the facts and circumstances. 

  
 40 

 Section 6.03 Annual Bonus.The Baxalta Group shall be responsible
for all annual bonus payments or other forms of cash incentive compensation (including commissions) to Transferred Employees (and Post-Distribution Baxalta Employees as part of the costs and expenses passed through to Baxalta pursuant to the
International Commercial Operations Agreement) in respect of any plan year, the payment date for which occurs on or after the applicable Transferred Employee’s Transfer Date. Notwithstanding the foregoing, the Parties intend to treat the
portion of 2015 ending on the Distribution Date as a separate performance period for purposes of 2015 annual bonuses. The bonuses attributable to such separate performance period earned by Transferred Employees shall be paid by Baxalta at
substantially the same time such bonuses are paid to Baxter Retained Employees, and to the extent that payment is conditioned upon continued employment, employment by the Baxalta Group shall be treated as employment by the Baxter Group. 

Section 6.04 Directors’ Plan. Effective as of or before the Distribution Date, Baxalta shall establish
the Baxalta Directors’ Plan, with terms and funding arrangements substantially similar to those of the Baxter Directors’ Plan as of the Distribution Date. The Parties shall use commercially reasonable efforts to take all actions necessary
or appropriate so that each outstanding Baxter Option or Baxter RSU Award granted under the Baxter Directors’ Plan shall be adjusted or converted as set forth in this Section 6.04. For the avoidance of doubt, the remainder of this
Section 6.04 applies only to grants (including those Baxter RSU Awards deferred pursuant to the Baxter Directors’ DCP) made under the Baxter Directors’ Plan (or any successor or predecessor plan), while Section 6.01
is intended to apply to other programs included within the Baxter Stock Programs. 
 (a) Baxter Options. As determined by the Baxter
Compensation Committee pursuant to its authority under the Baxter Directors’ Plan, each Baxter Option granted prior to January 1, 2015 (other than new hire grants made on or after July 1, 2014) that remains outstanding as of
immediately prior to the Distribution Date, regardless of by whom held, whether vested or unvested, shall be converted concurrently with the Distribution on the Distribution Date into both an Adjusted Baxter Option and a Baxalta Option. As
determined by the Baxter Compensation Committee pursuant to its authority under the Baxter Directors’ Plan, each Baxter Option granted on or after January 1, 2015 (or, with respect to new hire grants, on or after July 1, 2014) but
prior to the Distribution Date that remains outstanding as of immediately prior to the Distribution Date, regardless of by whom held, whether vested or unvested, shall be converted concurrently with the Distribution on the Distribution Date into
(i) an Adjusted Baxter Option in the case of any holder thereof who, as of immediately following the Distribution Date, is not serving on the Baxalta Board or who is serving on both the Baxter Board and the Baxalta Board or (ii) a Baxalta
Option in the case of any holder thereof who, as of immediately following the Distribution Date, is serving on the Baxalta Board, but not the Baxter Board. Each such adjusted or converted Option shall, except as otherwise provided in this
Section 6.04(a), be subject to the same terms and conditions (including with respect to vesting) after the Distribution Date as applicable to such Baxter Option immediately prior to the Distribution Date; provided, however,
that upon such adjustment or conversion: 
 (A) with respect to each Baxter Option granted prior to January 1, 2015
(other than new hire grants made on or after July 1, 2014), the number of Baxter Common Shares subject to such Option shall be unchanged from the number of Baxter Common Shares that were subject to the original unadjusted Baxter Option; 

  
 41 

 (B) with respect to each Baxter Option granted prior to January 1, 2015
(other than new hire grants made on or after July 1, 2014), the number of shares of Baxalta Common Stock subject to the Baxalta Option into which such Baxter Option is converted, rounded down to the nearest whole share, shall be equal to the
product obtained by multiplying (x) the number of Baxter Common Shares subject to the Baxter Option immediately prior to the Distribution Date times (y) the Distribution Ratio; 

(C) with respect to each Baxter Option granted on or after January 1, 2015 (or, with respect to new hire grants, on or
after July 1, 2014) to any holder thereof who, as of immediately following the Distribution Date, is not serving on the Baxalta Board or who is serving on both the Baxter Board and the Baxalta Board, the number of Baxter Common Shares subject
to such Adjusted Baxter Option (if any), rounded down to the nearest whole number, shall be equal to (1) the number of Baxter Common Shares subject to the Baxter Option immediately prior to the Distribution Date, divided by (2) the Baxter
Percentage; 
 (D) with respect to each Baxter Option granted on or after January 1, 2015 (or, with respect to new hire
grants, on or after July 1, 2014) to any holder thereof who, as of immediately following the Distribution Date, is serving on the Baxalta Board, but not the Baxter Board, the number of shares of Baxalta Common Stock subject to such Baxalta
Option (if any), rounded down to the nearest whole number, shall be equal to (1) the product obtained by multiplying (xx) the number of Baxter Common Shares subject to the Baxter Option immediately prior to the Distribution Date times (yy)
the Distribution Ratio, divided by (2) the Baxalta Percentage; 
 (E) the per share exercise price of each Adjusted
Baxter Option, rounded up to the nearest hundredth of a cent, shall be equal to (1) the Baxter Pre-Distribution Stock Value minus (2) the Baxter Pre-Distribution Option Value; and 

(F) the per share exercise price of each Baxalta Option, rounded up to the nearest hundredth of a cent, shall be equal to
(1) the Baxalta Stock Value minus (2) the Baxalta Pre-Distribution Option Value; 
 provided, however, that the exercise price, the
number of Baxter Common Shares and shares of Baxalta Common Stock subject to such options, and the terms and conditions of exercise of such options shall be determined in a manner consistent with the requirements of Code Section 409A. 

(b) Baxter RSU Awards. Each holder of Baxter RSU Awards granted prior to January 1, 2015 (other than new hire grants made on or
after July 1, 2014) that remain 

  
 42 

 
outstanding as of immediately prior to the Distribution Date, regardless of by whom held, whether vested or unvested, shall receive (in addition to retaining such Baxter RSU Awards) concurrently
with the Distribution on the Distribution Date a number of Baxalta RSU Awards equal to the product obtained by multiplying (i) the number of such Baxter RSU Awards held by such holder times (ii) the Distribution Ratio. Each Baxter RSU
Award granted on or after January 1, 2015 (or, with respect to new hire grants, on or after July 1, 2014) but prior to the Distribution Date that remains outstanding as of immediately prior to the Distribution Date, regardless of by whom
held, whether vested or unvested, shall be converted concurrently with the Distribution on the Distribution Date into (i) an Adjusted Baxter RSU Award in the case any holder thereof who, as of immediately following the Distribution Date, is not
serving on the Baxalta Board or who is serving on both the Baxter Board and the Baxalta Board or (ii) a Baxalta RSU Award in the case of any holder thereof who, as of immediately following the Distribution Date, is serving on the Baxalta Board,
but not the Baxter Board. Except as set forth in this Section 6.04(b), all Adjusted Baxter RSU Awards and Baxalta RSU Awards issued in accordance with this Section 6.04(b) shall be subject to substantially the same terms and
conditions (including with respect to vesting) immediately following the Distribution Date as applicable immediately prior to the Distribution Date for those Baxter RSU Awards from which such Adjusted Baxter RSU Awards and Baxalta RSU Awards were
converted; provided, however, that with respect to each Baxter RSU Award converted in accordance with the immediately preceding sentence: 

(A) the number of units represented by an Adjusted Baxter RSU Award shall be equal to (1) the number of units subject to
the Baxter RSU Award immediately prior to the Distribution Date, divided by (2) the Baxter Percentage; 
 (B) the
number of units represented by a Baxalta RSU Award shall be equal to (1) the product obtained by multiplying (xx) the number of units subject to the Baxter RSU Award immediately prior to the Distribution Date times (yy) the Distribution
Ratio, divided by (2) the Baxalta Percentage. 
 Section 6.05 Directors’ Deferred Compensation Plan.

 (a) Establishment of Baxalta Directors’ DCP. Effective as of or before the Distribution Date, Baxalta shall establish the
Baxalta Directors’ DCP, with terms substantially similar to those of the Baxter Directors’ DCP as of the Distribution Date. The portion of the compensation paid to a director of Baxalta in the year that includes the Distribution Date that
is deferred pursuant to the Baxter Directors’ DCP shall be determined by the deferral election, if any, made by such director for such year pursuant to the Baxter Directors’ DCP. 

(b) Assumption of Directors’ DCP Liabilities and Transfer from Baxter Directors’ DCP. 

(i) As of the Distribution Date, Baxalta shall, and shall cause the Baxalta Directors’ DCP to, assume all Liabilities for
all obligations under the Baxter 

  
 43 

 
Directors’ DCP for the benefits of each person who will serve on the Baxalta Board, but not the Baxter Board, as of immediately following the Distribution Date, together with his or her
beneficiaries and/or alternate payees, determined as of the applicable Distribution Date, and Baxter and the Baxter Directors’ DCP shall be relieved of all Liabilities for those benefits. To the maximum extent permitted by Treasury Regulations
Section 1.409A-1(h)(4), a member of the Baxter Board whose benefit under the Baxter Director’s DCP is transferred to the Baxalta Directors’ DCP shall not be considered to have undergone a “separation from service” for
purposes of Code Section 409A and the Baxter Directors’ DCP solely by reason of the Separation, regardless of whether he continues to serve on the Baxter Board immediately following the Distribution Date. 

(ii) Baxter shall retain all of the Liabilities under the Baxter Directors’ DCP with respect to the benefits of each
person who will serve on both the Baxalta Board and the Baxter Board as of immediately following the Distribution Date, together with his or her beneficiaries and/or alternate payees. The time and form of payment of such Liabilities shall be based
upon the date on which such persons terminate their service on the Baxter Board regardless of whether they continue to serve on the Baxalta Board. 

(iii) As of or as soon as practicable after the Distribution Date, the Parties shall cooperate to cause the accounts of each
person who will serve on the Baxalta Board, but not the Baxter Board, as of immediately following the Distribution Date, participating in the Baxter Directors’ DCP to be transferred to the Baxalta Directors’ DCP. Baxalta shall
(A) credit each such director’s account with (1) the amount deferred by such individual into the Baxter Directors’ DCP as of the Distribution Date, plus (2) any employer contributions, whether vested or unvested, deemed to
have been made in relation to the amount described in (1), including, in each case, any earnings thereon, and (B) recognize and honor all deferral and distribution elections made by such individual (including any deferral election applicable to
any amount earned but not yet paid as of the Distribution Date). 
 (iv) The accrued benefit of each director under the
Baxter Directors’ DCP as of the applicable Transfer Date shall be payable under the Baxalta Directors’ DCP at the same time and in the same form that would have been paid under the Baxter Directors’ DCP, treating such director’s
separation from service from the Baxalta Group as if it were a separation from service from the Baxter Group, and taking into account any election made by the director relating to the time and form of his payment under the Baxter Director’s
DCP. 
 (c) Baxter Directors’ DCP after Transfer Date. From and after the Distribution Date, each person who will serve on the
Baxalta Board, but not the Baxter Board, as of immediately following the Distribution Date shall not participate in or accrue any benefits under the Baxter Directors’ DCP. Without limiting the generality of the foregoing, each such person shall
cease to participate in the Baxter Directors’ DCP effective as of the Distribution Date. The Baxter Directors’ DCP shall continue to be responsible for Liabilities in respect of members of the Baxter Board and their beneficiaries and/or
alternate payees. 

  
 44 

 ARTICLE VII 

MISCELLANEOUS 

Section 7.01 Transfer of Records and Information. Baxter shall transfer to Baxalta originals or copies of any and
all employment records and information (including, but not limited to, any personnel files, performance reviews, and medical, social security and tax files and forms) with respect to Transferred Employees and other records reasonably required by
Baxalta to enable Baxalta properly to carry out its obligations under this Agreement. Such transfer of records and information generally shall occur as soon as administratively practicable on or after the Distribution Date (or, if later, the
applicable Transfer Date) and shall in each case be required and shall occur only to the extent permitted by applicable local Law; provided that it is understood and agreed that certain records required to effect the contemplated transfer of
employment may be provided prior to the Transfer Date to the extent required by applicable local Law. Each Party will permit the other Party reasonable access to Employee records and information, to the extent reasonably necessary for such accessing
Party to carry out its obligations hereunder. 
 Section 7.02 Cooperation. Each Party shall upon reasonable
request provide the other Party and the other Party’s respective Affiliates, agents, and vendors all information reasonably necessary to the other Party’s performance of its obligations hereunder. The Parties agree to use their respective
best efforts and to cooperate with each other in order to carry out their obligations hereunder and to effectuate the terms of this Agreement. 

Section 7.03 Employee Agreements. Effective as of the applicable Transfer Date of each Transferred Employee, Baxter
and the applicable members of the Baxter Group hereby assign to Baxalta or another member of the Baxalta Group, to the extent a Transferred Employee did not otherwise sign an Employee Agreement to effect his or her transfer to and hiring by the
Baxalta Group, each Employee Agreement entered into between a member of the Baxter Group and any Baxalta Employee, and all rights and obligations thereunder; provided, however, that Baxter and the Baxter Group shall retain all rights under
each Employee Agreement to the extent that such rights are related to any continuing Liability of the Baxter Group not assumed by Baxalta in connection with the Separation and Distribution (including herein). Upon written request by Baxter or the
Baxter Group, Baxalta or the Baxalta Group shall make available to Baxter or the Baxter Group the original copy of any written Employee Agreement (and a summary of the terms of any unwritten Employee Agreement) that was assigned to Baxalta or the
Baxalta Group under this Agreement. 
 Section 7.04 Repayment Assets. Effective as of the Distribution Date, the
Baxter Group shall be entitled to all Employee Recoupment Assets in respect of Baxter Retained Employees and Former Employees, and effective as of the applicable Transfer Date, the Baxalta Group shall be entitled to all Employee Recoupment Assets in
respect of Baxalta Employees. 
 Section 7.05 Compliance. The agreements and covenants of the Parties hereunder
shall at all times be subject to the requirements and limitations of applicable Law (including, for purposes of Article IV, local rules and customs relating to the treatment of pension plans) and collective bargaining agreements. Where an agreement
or covenant of a Party 

  
 45 

 
hereunder cannot be effected in compliance with applicable Law or an applicable collective bargaining agreement, the Parties agree to negotiate in good faith to modify such agreement or covenant
to the least extent possible in keeping with the original agreement or covenant in order to comply with applicable Law or such applicable collective bargaining agreement. Each provision of this Agreement is subject to and qualified by this
Section 7.05, whether or not such provision expressly states that it is subject to or limited by applicable Law or by applicable collective bargaining agreements. Each reference to the Code, ERISA, or the Securities Act or any other Law
shall be deemed to include the rules, regulations, and guidance issued thereunder. 
 Section 7.06 Preservation of
Rights. Unless expressly provided otherwise in this Agreement, nothing herein shall be construed as a limitation on the right of the Baxter Group or the Baxalta Group to (a) amend, modify or terminate any Benefit Plan or
(b) terminate the employment of any Employee. 
 Section 7.07 Reimbursement. The Parties acknowledge that the Baxter
Group, on the one hand, and the Baxalta Group, on the other hand, may incur costs and expenses (including, without limitation, contributions to Benefit Plans and the payment of insurance premiums) which are, as set forth in this Agreement, the
responsibility of the other Party. Accordingly, the Parties agree to reimburse each other for Liabilities and obligations for which such Party is responsible, and shall provide such reimbursement reasonably promptly and in accordance with the terms
of any agreement between the Parties or their Affiliates expressly addressing such matters. 
 Section 7.08 Matching Grant
Plan. Baxter covenants and agrees that the Baxter International Foundation shall retain all Liabilities under the Matching Gifts Program with respect to donations made by any Transferred Employee prior to the Transfer Date. Baxter covenants
and agrees that the Baxter International Foundation is to match or cause to be matched all eligible donations made prior to the Distribution Date, in accordance with the terms of the Matching Gifts Program. 

Section 7.09 Not a Change in Control. The Parties acknowledge and agree that the transactions contemplated by the
Separation and Distribution Agreement and this Agreement do not constitute a “change in control” or a “change of control” for purposes of any Benefit Plan. 

Section 7.10 Incorporation by Reference. The following sections of the Separation and Distribution Agreement are hereby
incorporated into this Agreement by reference: Section 9.01. Counterparts, Entire Agreement, Corporate Power, Facsimile Signatures; Section 9.02. Governing Law; Section 9.03. Assignability; Section 9.04. Third Party
Beneficiaries; Section 9.05. Notices; Section 9.06. Severability; Section 9.07. Force Majeure; Section 9.08. No Set Off; Section 9.09. Responsibility for Expenses; Section 9.10. Headings; Section 9.11. Survival of
Covenants; Section 9.13. Waivers; Section 9.14. Amendments; Section 9.15. Interpretation; Section 9.16. Public Announcements; Section 9.17. Specific Performance; and Section 9.18. Mutual Drafting. 

Section 7.11 Limitation on Enforcement. This Agreement is an agreement solely between the Parties. Nothing in this
Agreement, whether express or implied, shall be construed to: (a) confer upon any current or former Employee of the Baxter Group or the Baxalta 

  
 46 

 
Group, or any other person any rights or remedies, including, but not limited to any right to (i) employment or recall; (ii) continued employment or continued service for any specified
period; or (iii) claim any particular compensation, benefit or aggregation of benefits, of any kind or nature; or (b) create, modify, or amend any Benefit Plan. 

Section 7.12 Further Assurances and Consents. In addition to the actions specifically provided for elsewhere in this
Agreement, each of the Parties hereto shall use commercially reasonable efforts to (a) execute and deliver such further instruments and documents and take such other actions as the other party may reasonably request to effectuate the purposes
of this Agreement and carry out the terms hereof; (b) take, or cause to be taken, all actions, and do, or cause to be done, all things, reasonably necessary, proper or advisable under applicable Laws and agreements or otherwise to consummate
and make effective the transactions contemplated by this Agreement, including, without limitation, using commercially reasonable efforts to obtain any consents and approvals and to make any filings and applications necessary or desirable to
consummate the transactions contemplated by this Agreement; provided that no Party shall be obligated to pay any consideration therefor (except for filing fees and other similar charges) to any third party from whom those consents, approvals
and amendments are required or to take any action or omit to take any action if the taking of action or the omission to take action would be unreasonably burdensome to the Party or the business thereof. 

Section 7.13 Third Party Consent. If the obligation of any Party under this Agreement depends on the consent of a third
party, such as a vendor or insurance company, and that consent is withheld, the Parties shall use commercially reasonable efforts to implement the applicable provisions of this Agreement to the fullest extent practicable. If any provision of this
Agreement cannot be implemented due to the failure of a third party to consent, the Parties shall negotiate in good faith to implement the provision in a mutually satisfactory manner, taking into account the original purposes of the provision in
light of the Distribution and communications to affected individuals. 
 Section 7.14 Effect if Distribution Does Not
Occur. If the Distribution does not occur, then all actions and events that are to be taken under this Agreement, or otherwise in connection with the Distribution, shall not be taken or occur, except to the extent specifically provided by
Baxter. 
 Section 7.15 Disputes. The Parties agree to use commercially reasonable efforts to resolve in an amicable
manner any and all controversies, disputes and claims between them arising out of or related in any way to this Agreement. The Parties agree that any controversy, dispute or claim (whether arising in contract, tort or otherwise) arising out of or
related in any way to this Agreement that cannot be amicably resolved informally will be resolved pursuant to the dispute resolution procedures set forth in Article VII of the Separation and Distribution Agreement. 

Section 7.16 Reverse Jurisdiction. Notwithstanding anything in this Agreement to the contrary, with the exception of
Article I, Section 2.01 and this Section 7.16, the parties acknowledge and agree that for each of the entities or countries listed in Schedule 7.16, where the context so requires in accordance with the
applicable local Conveyance and Assumption Instruments, each reference to “Baxalta” in this Agreement shall be construed as a 

  
 47 

 
reference to “Baxter,” and each reference to “Baxter” in this Agreement shall be construed as a reference to “Baxalta.” For the avoidance of doubt and where such
treatment is reasonable in light of the context, this Section 7.16 shall be interpreted to provide substantially the same treatment for the entities or jurisdictions listed in Schedule 7.16 (but with the Baxter and Baxalta roles
reversed) to Baxter Retained Employees who are legally employed by the Baxalta Group for a period prior to such Employee’s legal transfer back to the Baxter Group by agreement of the Parties, as the treatment herein with respect to
Post-Distribution Baxalta Employees. 
 [SIGNATURE PAGE FOLLOWS] 

  
 48 

 The Parties have caused this Agreement to be signed by their authorized representatives as of the
date of this Agreement. 
  

			
	BAXTER INTERNATIONAL INC.
		
	By:		  

		
	Title:		  

	
	BAXALTA INCORPORATED
		
	By:		  

		
	Title:EX-10.6

 Exhibit 10.6 

TRADEMARK LICENSE AGREEMENT 

THIS TRADEMARK LICENSE AGREEMENT (this “Agreement”), dated and effective as of
[—], 2015 between BAXTER INTERNATIONAL INC., a corporation organized under the laws of the state of Delaware with a primary address at One Baxter Parkway, Deerfield, Illinois 60015
(“Baxter”), and BAXALTA INCORPORATED, a corporation organized under the laws of the State of Delaware with a primary address at One Baxter Parkway, Deerfield, Illinois 60015 (“Baxalta”). All references to
Baxalta herein shall include its Subsidiaries (and its and their respective permitted sublicensees) unless the context clearly indicates otherwise. 

R E C I T A L S: 
 WHEREAS,
Baxter and Baxalta have entered into that certain Separation and Distribution Agreement dated as of the date hereof (the “Distribution Agreement”) that, among other things, sets forth the terms and conditions pursuant to which the
Baxalta Business is separated from the Baxter Business; 
 WHEREAS, Baxter or Subsidiaries of Baxter are the owners of the trademarks set
forth in Schedule A to this Agreement and all other trademarks incorporating the trademarks set forth in Schedule A (collectively, the “Trademarks”); 

WHEREAS, Baxalta owns certain trademarks (collectively, the “Baxalta Marks”); 

WHEREAS, Baxalta and Baxalta Subsidiaries (hereinafter, “Baxalta”) are currently using the Trademarks in connection
with the Baxalta Business and desire to obtain a license from Baxter (including on behalf of its applicable Subsidiaries) to allow them to continue to use the Trademarks in connection with the Baxalta Business after the Separation; 

WHEREAS, Baxalta desires to obtain certain services from Baxter and its Subsidiaries following the Effective Time pursuant to the Ancillary
Agreements (the “Ancillary Services”), and desires to license the Baxalta Marks to Baxter and its Subsidiaries in order to allow those services to be provided; and 

WHEREAS, the Parties have entered into this Agreement setting out the terms and conditions upon which (i) Baxalta shall be permitted to
continue its use of the Trademarks after the Separation and (ii) Baxter shall be permitted to use the Baxalta Marks after the Separation. 

NOW, THEREFORE, in consideration of the premises and mutual covenants, agreements and provisions herein contained, and intending to be legally
bound, the Parties hereto agree as follows: 
  

	 	1.	GRANT OF LICENSE 

 (a) Subject to and in accordance with the terms and
conditions of this Agreement, Baxter hereby grants (including on behalf of its applicable Subsidiaries) to Baxalta and its applicable Subsidiaries, and Baxalta hereby accepts (including on behalf of its Subsidiaries), a worldwide, non-exclusive,
terminable, royalty-free license to use the Trademarks during the Term (as defined herein) solely in connection with Baxalta Business in a manner 

 
consistent with the past practice of the Baxalta Business. Notwithstanding anything to the contrary herein, Baxalta and its Subsidiaries shall not (i) register domain names that incorporate
the Trademarks or use the Trademarks in the address of any social media (e.g., Facebook, Twitter) or similar or successor media or (ii) use the Trademarks in any trade name, corporate name or “doing business as” name. 

(b) Subject to and in accordance with the terms and conditions of this Agreement, Baxalta hereby grants to Baxter and its Subsidiaries, and
Baxter hereby accepts, a worldwide, non-exclusive, sublicensable, assignable (in accordance with Section 7(d) and as set forth below), royalty-free license to use the Baxalta Marks; provided that such license shall be used only in
connection with the good faith performance by Baxter or any of its Subsidiaries (or their applicable subcontractors, sublicensees and assignees) of the Ancillary Services in accordance with the terms of the Ancillary Agreements. Baxter and its
Subsidiaries shall, subject to the immediately preceding sentence, use the Baxalta Marks as they may in their good faith judgment determine is necessary or desirable in connection with the performance of any of the Ancillary Services. Baxter hereby
agrees that the Baxalta Marks are owned solely and exclusively by Baxalta in the same manner in all respects as Baxalta has agreed with respect to the Trademarks pursuant to Section 3 below. In addition to the assignment rights set forth
in Section 7(d), Baxter and its Subsidiaries shall have the right to assign and/or sub-license the foregoing right and license, with the prior written consent of Baxalta (not to be unreasonably
withheld), to one or more Third Parties for the sole purpose of performing the Ancillary Services under any Ancillary Agreement (and with Baxter guaranteeing the performance of such Third Party only if and to the extent provided under the applicable
Ancillary Agreement pursuant ot which the service is being provided); provided that such Third Party has agreed to comply with the applicable provisions of this Agreement; provided further, that Baxalta’s consent will not
be required if Baxter or its applicable Subsidiaries use such Third Party to perform such services in connection with their continuing businesses or to the extent the terms and conditions of the applicable Ancillary Agreement provide for the
expectation that a Third Party will perform such services. Baxalta hereby releases and agrees to indemnify and hold harmless Baxter, Baxter’s Subsidiaries and their respective officers, directors, employees, stockholders, agents and
representatives (collectively, the “Indemnitees”) from and against any and all Liabilities arising out of, or resulting from, Baxter’s or any of its Subsidiaries’ use of the Baxalta Marks during the term(s) of the
Ancillary Agreements, except to the extent of any Liability that is an express obligation of Baxter or any of its Subsidiaries under the terms of the Ancillary Agreement pursuant to which such Liability arises (as though this Agreement were a part
of such Ancillary Agreement). For the avoidance of doubt, all limitations on liability and related provisions of the applicable Ancillary Agreement pursuant to which a claim or Liability against Baxter or any of its Subsidiaries hereunder arises
shall apply equally to this Agreement as though this Agreement were part of (and only included in) the Ancillary Agreement under which Baxter or its Subsidiaries is performing the Ancillary Services with the use of the Baxalta Marks. The
indemnification described in this Section 1(b) shall be the sole and exclusive monetary remedy against the Indemnitees in connection with or arising pursuant to this Agreement or otherwise in connection with the license granted to Baxter
and its Subsidiaries of the Baxalta Marks hereunder. 

  
 2 

	 	2.	USE OF THE TRADEMARKS 

 (a) Subject to the terms and conditions of this
Agreement, Baxalta may continue to use the Trademarks (i) in the identical visual presentations (including not being larger in size), and (ii) on the same materials, including, but not limited to, the products themselves, packaging,
labeling and promotional materials (collectively, “Materials”), as it is using the Trademarks in connection with the Baxalta Business as of the Effective Time. For purposes of clarity, Baxalta shall not, without Baxter’s prior
written consent, (A) change, modify or create any variation of the Trademarks (or permit any such change, modification or variation), including by combining a Trademark with a prefix or suffix or modifying any word or term therein or
(B) conjoin (or permit to be conjoined) any word or term with a Trademark so as to form a composite or combined trademark. 
 (b)
Baxalta acknowledges that the Trademarks licensed hereunder have established valuable goodwill and that it is important to Baxter that this valuable goodwill and reputation be preserved. Accordingly, Baxalta agrees that the products or other
Materials with which the Trademarks are used by Baxalta or its Subsidiaries (including, for the avoidance of doubt, their applicable permitted sublicensees) shall for the Term of the Trademark license meet quality, style and appearance standards
that are substantially equivalent to or higher than those standards maintained by Baxter and its Subsidiaries immediately prior to the Distribution Date. Baxalta covenants and agrees that all of its and its Affiliates’ activities in connection
with such Trademarks licensed to it by Baxter will be conducted in conformity with all applicable Laws. Baxalta and its Subsidiaries shall not do anything to prejudice or endanger the value or validity of the Trademarks, and shall not:
(a) take, maintain or direct any action that is inconsistent with Baxter’s ownership of the Trademarks; (b) assert any claim of right in or ownership of the Trademarks or challenge Baxter’s right, title, interest in, or ownership
of, its Trademarks or its registrations therefor; or (c) take any action that would diminish or dilute the value, reputation or goodwill of the Trademarks or that would otherwise denigrate the image and reputation of Baxter, tarnish the
Trademarks or harm or disparage Baxter or any of its Subsidiaries (including with respect to any goodwill in the Trademarks). 
 (c) Baxalta
agrees that the manufacture, sale and distribution of the Materials bearing the Trademarks, including the use of the Trademarks in advertising and promotional materials, shall continue to be in accordance with all applicable federal, state and local
Laws and regulations. 
 (d) Any other use of the Trademarks by Baxalta or any of its Subsidiaries (or any of their sublicensees), including
uses in a different visual presentation or on different Materials than in use as of the Effective Date (“New Uses”), is prohibited without the prior written approval of Baxter; provided, however, that to the extent
such New Uses are reasonably necessary for regulatory reasons such approval is not to be unreasonably withheld. Baxalta and Baxter understand and agree (without limiting the written approval rights set forth in the immediately preceding sentence)
that New Uses may be necessary in the ordinary course of business as a result of product extensions and expansions (including approvals of products in the pipeline) during the Term, and that Baxter’s consent and oversight of the use of the
Trademarks (including for such New Use) shall include Baxter’s right to review samples and otherwise review the related use of the Trademarks. Baxalta shall cooperate with Baxter in its oversight

  
 3 

 
and review of any use or requested use of the Trademarks, including with respect to any New Uses, including as Baxter deems necessary to maintain quality control over, and validity and
enforceability with respect to, the Trademarks. Baxalta acknowledges and agrees that it and its Subsidiaries (and their respective sublicensees) shall be bound by any restrictions placed upon such New Uses by Baxter, including restrictions
respecting the usage of the Trademarks and the quality of any Materials in connection with which the Trademarks are to be used. 
 (e)
Baxter reserves all rights of reasonable review and inspection which are necessary to monitor and confirm compliance with this Agreement, including Sections 2(a) and 2(d), with respect to the Trademarks licensed to Baxalta hereunder.
In addition, upon reasonable written request by Baxter from time to time, Baxalta shall furnish to Baxter, for its inspection, samples of products or materials that bear or are used in connection with the Trademarks and other information relating to
the scope of usage of Trademarks by Baxalta thereof, including information regarding the jurisdictions in which the Trademark is then being used by Baxalta and a description of how the Trademarks are being used. Baxter shall have the right to direct
Baxalta to immediately cease any particular use of such Trademark that Baxter reasonably determines is inconsistent with the rights granted to Baxalta hereunder and that has or reasonably could be expected to have a material and detrimental effect
on the value, reputation or goodwill of such Trademark, or that would otherwise denigrate in any material respect the image and reputation of Baxter and such other party shall comply with such directions reasonably given by Baxter in accordance with
the foregoing. 
  

	 	3.	PROPRIETARY RIGHTS 

 (a) Baxalta acknowledges and agrees that Baxter and its applicable
Subsidiaries are the sole and exclusive owners of the Trademarks, and that Baxalta and its Subsidiaries (and no Third Party) shall receive no right, title or interest in and to the Trademarks, including any trademark, service mark, copyright or
other proprietary rights as a result of this Agreement. Without limiting the foregoing, this Agreement and the licenses and rights granted herein do not and shall not be construed to confer any rights upon Baxalta or any of its Subsidiaries by
implication, estoppel or otherwise as to any of the Trademarks or any other intellectual property of Baxter or any of its Subsidiaries. Any and all goodwill arising from Baxalta’s or its Subsidiaries’ use of the Trademarks shall inure
solely to the benefit of Baxter and neither during the term of the respective Trademark licenses nor after their termination or expiration shall either party assert any claim to Baxter’s Trademarks or such goodwill relating thereto as a result
of the use of such Trademarks pursuant to the license granted to Baxalta hereunder. Each party agrees that all goodwill in the Trademarks licensed to Baxalta hereunder that may be held by Baxalta notwithstanding the foregoing is hereby assigned by
Baxalta and its Subsidiaries (and their respective sublicensees) to Baxter, without the need for any further action by any person. 
 (b)
Baxalta shall not, for any reason, whether during or after the termination of this Agreement, do or authorize another to do, any of the following: (i) represent to others in any manner that it owns or has any ownership rights in the Trademarks,
(ii) apply for federal, state, or national registration of the Trademarks or any mark incorporating the Trademarks; or (iii) impair, dispute or contest the validity of Baxter’s or any of Baxter’s Subsidiaries right, title and
interest in and to the Trademarks or any goodwill associated therewith. 

  
 4 

 (c) Only those rights specifically granted hereunder are granted to Baxalta and all other rights
are expressly reserved by Baxter and its Subsidiaries. 
 (d) Baxalta shall not, and shall cause its Subsidiaries (and its and their
respective sublicensees) to not, expressly or by implication, do business as or represent themselves as Baxter or any of its Affiliates, and shall ensure that there is no confusion that any of Baxalta or its Subsidiaries (or any of their respective
sublicensees) are affiliated with Baxter or any of its Subsidiaries and, if such confusion occurs, shall promptly remediate such confusion. 
  

	 	4.	ENFORCEMENT; MAINTENANCE 

 (a) Baxalta will promptly notify Baxter of any apparent
infringement of, or challenge to, any Trademark licensed to Baxalta or any unfair competition, passing off, dilution or impairment or unauthorized trademark application or registration with respect thereto that comes to the attention of Baxalta.
Baxter will at all times have the right, in its sole discretion, to take whatever steps it deems necessary or desirable to protect any Trademarks from all harmful or wrongful activities of Third Parties. Such steps may include, but are not limited
to, the filing and prosecution of: (i) litigation against infringement or unfair competition or passing off by Third Parties, (ii) opposition proceedings against applications for trademark or service mark registration for trademarks that
are confusingly similar to any one or more of the Trademarks, (iii) cancellation proceedings against registration of trademarks that are confusingly similar to any one or more of the Trademarks and (iv) other appropriate administrative
actions. Baxalta shall cooperate with Baxter, at Baxter’s reasonable request, in any such actions. Except as set otherwise forth in this Agreement (including Baxter’s rights to indemnification described herein), Baxter shall be responsible
for Baxalta’s reasonable costs and expenses incurred in such cooperation. 
 (b) Baxter shall at all times have the right, but not the
obligation, to take whatever steps it deems necessary or desirable to defend all claims that the use of the Trademarks infringe, dilute, or constitute unfair competition or passing off with respect to the rights of a Third Party. Baxalta shall have
the right to participate in such defense at its own expense to protect its rights under this Agreement relating to the Trademarks. If Baxalta is named as a party to such claim and Baxter is not so named, Baxter shall have the right to defend such
action at its own expense, subject to Baxalta’s right to participate in such defense at its own expense. Each party shall cooperate, at the other party’s reasonable request, in such defense, and the other party shall be responsible for the
cooperating party’s reasonable expenses (subject to Baxter’s rights to indemnification described herein) incurred in such cooperation. Baxalta shall not enter into any agreement, consent order or other resolution of a claim by or against a
Third Party that affects the Trademarks without Baxter’s prior written approval. To the extent Baxter’s failure to approve such agreement, consent order or other resolution would result in a materially adverse effect on Baxalta’s use
of the Trademarks that are the subject thereof, approval shall not be unreasonably withheld or delayed. Baxalta shall advise Baxter immediately if it becomes aware of any unauthorized use of the Trademarks by any Third Party. Baxalta shall take no
steps to contact such Third Party without Baxter’s prior written permission. 
 (c) If Baxalta becomes aware of information (including
a Third Party complaint) relating to any product or other Material bearing a Trademark that indicates that such 

  
 5 

 
product or Material may not conform to a quality standard at least as high as the historical quality of such products and associated labels manufactured by or on behalf of Baxter or any of its
Subsidiaries prior to the Effective Time, or that potential adulteration, misbranding, or other issues have arisen that relate to the safety or efficacy of such product or Material, it shall promptly so notify Baxter. At Baxter’s instruction,
Baxalta shall promptly correct any nonconformity with such standard. Baxter shall have the right, from time to time upon notice to Baxalta, itself or through a Third Party auditor, to conduct an audit of Baxalta’s or its manufacturer’s
facilities to verify that the products or Materials meet such standard. As part of such audit, Baxter or its Third Party auditor shall have the right to inspect the products or Materials. Additionally, upon Baxter’s request from time to time,
Baxalta shall provide to Baxter representative samples of any such products or Materials to verify compliance with such standard. 
 (d) To
the extent Baxalta is requested by Baxter to do so, Baxalta shall reasonably assist Baxter, at Baxter’s cost and upon its reasonable request, in complying with any formalities to properly maintain and protect Baxter’s Trademark under
applicable Law, including, but not limited to, executing applications for recordation of Baxalta as a registered user with the appropriate authorities (e.g. by executing a short-form trademark license consistent with this Agreement for recordal
purposes) and any and all other instruments and documents as may be reasonably necessary or advisable to properly maintain and protect the interests of Baxter in the Trademarks. For the duration of the Term and a period of at least five
(5) years thereafter, Baxalta shall keep proper records and shall preserve suitable evidence that the Trademark has been used. At any time up to five years following the Term, on request, Baxalta shall provide Baxter promptly and in any event
within fifteen (15) Business Days with documentary evidence (e.g. invoices, brochures, packaging, advertising or promotion materials related to the Trademark) that evidences proper use of the Trademark for a period of no less than five
(5) years preceding Baxter’s request. 
  

	 	5.	TERM 

 (a) The term of this Agreement (including any extension agreed upon in writing by
Baxter and subject to Section 5(e), the “Term”) shall be determined as follows: 
 (i) For uses
of the Trademarks on stationery, letterhead, business cards, signage and similar uses, six months from the Distribution Date; and 

(ii) For all other uses of the Trademarks in accordance with this Agreement, the later of (A) three years from the
Separation Date and (B) one year after the local closing (or other sale, transfer or wind-down) of a Deferred Baxalta Local Business to the extent of the use of the Trademarks in the operation of such Deferred Baxalta Local Business. 

(b) Notwithstanding the expiration of the Term, Baxalta shall be entitled to use existing Materials bearing the Trademarks that were produced
in the ordinary course of business prior to the conclusion of the Term in the same manner as was permitted during the Term (including subject to Section 5(e) below) and shall not be required to recall or withdraw uses of the Trademarks
from the market; provided that such use shall not continue beyond (i) 18 

  
 6 

 
months with respect to Materials other than inventory and Materials that accompany such inventory in the ordinary course of business and (ii) the expiration date of any inventory having a
shelf life (including the Materials that accompany such inventory in the ordinary course of business). 
 (c) In the event that Baxalta is
unable to discontinue use of the Trademarks within the Term despite use of commercially reasonable efforts, Baxalta may request in writing from Baxter consent for an appropriate extension, such consent not to be unreasonably withheld. The consent
request shall contain a detailed explanation as to why Baxalta is unable to discontinue use of the Trademarks, together with a copy of all applicable supporting documentation. 

(d) At the end of the Term, (or in the case of an extension pursuant to Section 5(b) or 5(c), upon the conclusion of that
extension), Baxalta shall, to the extent reasonably practical, cause to be destroyed, removed or obliterated all remaining Materials (regardless of medium) controlled by Baxalta on or in which any of the Trademarks appear. 

(e) Notwithstanding the foregoing, Baxalta shall use commercially reasonable efforts to take all such actions as are necessary (including
obtaining, as soon as practicable, all necessary permits) to allow it to conduct the Baxalta Business without using the Trademarks, and shall discontinue its use of the Trademarks as soon as reasonably practicable in each jurisdiction (subject to run-off use in accordance with Section 5(b)). For the avoidance of doubt, the Term for any Trademark shall expire on a rolling basis (including by product or jurisdiction once Baxalta is able to market
and sell such product in any such jurisdiction without the use of such Trademark) upon Baxalta having the ability to conduct the Baxalta Business without the use of such Trademark, subject to Section 5(b) and 5(c). 

 

	 	6.	TERMINATION 

 Notwithstanding anything to the contrary contained herein, Baxter shall
have the right to immediately terminate this Agreement if Baxalta breaches any of its obligations under this Agreement and fails to cure such breach within forty-five (45) days following receipt of written notice from Baxter, or such other
reasonable period of time as agreed upon in writing by the Parties. 
  

	 	7.	ASSIGNABILITY 

 (a) This Agreement shall be binding upon and inure to the benefit of the
Parties and their respective successors and assigns. 
 (b) Baxalta may grant sublicenses hereunder solely to bona fide Third Party
collaborators, co-marketers, distributors or other commercial partners of Baxalta or its Subsidiaries, in each case, only to the extent such sublicense is: (i) pursuant to a written agreement with Baxalta or its Subsidiaries; and
(ii) reasonably necessary for and limited to the purpose of the research, development, collaboration, co-marketing, distribution or other similar arrangement with Baxalta or its Subsidiaries within the scope of use permitted in this Agreement.
Baxalta shall provide notice to Baxter of each sublicense granted hereunder, and shall provide Baxalta with the name and address of each sublicensee and a description of the rights granted; 

  
 7 

 
provided such notice requirement does not apply to research agreements, clinical study agreements, investigator initiated studies, service agreements, manufacturing agreements,
distribution agreements, promotion agreements and the like that may contain a limited express or implied sublicense to perform the research, study, services or other activities that are the subject of said agreement. 

(c) Except as set forth in Section 7(b), Baxalta shall not assign, subcontract, transfer, or otherwise dispose of its rights,
duties or obligations under this Agreement without the prior written consent of Baxter, which may be granted or refused in Baxter’s sole discretion, except that Baxalta may assign the Agreement in connection with (i) a sale of all or
substantially all of the assets of the Baxalta Business so long as Baxalta remains directly liable for all obligations hereunder and the assignee assumes all the obligations of Baxalta thereto or (ii) a sale of a product line, so long as
Baxalta remains directly liable for all obligations hereunder and the assignee assumes all the obligations of Baxalta thereto. 
 (d) Baxter
may assign the Agreement in whole in connection with (i) a sale of all or substantially all of the assets of Baxter so long as Baxter remains directly liable for all obligations hereunder and the assignee assumes all the obligations of Baxter
thereto or (ii) a sale of a product line or other part of the business responsible for providing the applicable services under the Ancillary Agreements, so long as Baxter remains directly liable for all obligations hereunder and the assignee
assumes all of the obligations of Baxter thereto. 
  

	 	8.	COMPLIANCE WITH LAWS 

 Baxalta shall ensure that its use of the Trademarks and the use of
the Trademarks by its Subsidiaries and their respective sublicensees shall comply in all respects with applicable Laws. In the event that the Law of a particular jurisdiction includes additional requirements that are necessary to prevent a Trademark
from becoming invalid or unenforceable other than registration of a Trademark (e.g., trademark notices of marking requirements, if required by the Laws of a jurisdiction), then, at the request of a party, the other party shall reasonably cooperate
to assist in implementing or otherwise reasonably satisfying such requirements, and the requesting party shall reimburse the other party for its reasonable costs and expenses incurred in connection therewith. 

 

	 	9.	SUBSIDIARIES 

 Baxter shall cause to be performed, and hereby guarantees (subject to the
limitations set forth in Section 1(b)) the performance of, all actions, agreements and obligations set forth herein to be performed by a Baxter Subsidiary and Baxalta shall cause to be performed, and hereby guarantees the performance of,
all actions, agreements and obligations set forth herein to be performed by a Baxalta Subsidiary. 
  

	 	10.	SURVIVAL OF COVENANTS 

 Except as expressly set forth in this Agreement, the covenants
and other agreements contained in this Agreement, and liability for the breach of any obligations contained herein or therein, shall survive the term of this Agreement and shall remain in full force and effect thereafter. 

  
 8 

	 	11.	AMENDMENTS 

 No provisions of this Agreement shall be deemed amended, supplemented or
modified unless such amendment, supplement or modification is in writing and signed by an authorized representative of both Parties. No provisions of this Agreement shall be deemed waived unless such waiver is in writing and signed by the authorized
representative of the Party against whom it is sought to be enforced. 
  

	 	12.	MISCELLANEOUS 

 (a) Capitalized terms not defined herein shall have the meanings assigned
to them in the Distribution Agreement. 
 (b) Articles VII and IX of the Distribution Agreement are hereby incorporated into this Agreement
by reference; provided that in the event of any conflict between the express terms of any other Section of this Agreement (including references to any Ancillary Agreement) and the Distribution Agreement, then this Agreement shall control to
the extent of such conflict. 
 * * * * * 

  
 9 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement by their duly authorized
officers as of the date first written above. 
  

			
	BAXTER INTERNATIONAL INC.
		
	Signed:		  

		
	Name:		  

		
	Title:		  

		
	Date:		  

	
	BAXALTA INCORPORATED
		
	Signed:		  

		
	Name:		  

		
	Title:		  

		
	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}]]